No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d2ds0A_, 1.0000, 0.00, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH 6 -SIALYLLACTOSE
2, d2dryA_, 0.9976, 0.21, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT
3, d2drzA_, 0.9975, 0.21, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH LACTOSE
4, d2ds0B_, 0.9856, 0.54, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH 6 -SIALYLLACTOSE
5, d2dryB_, 0.9785, 0.67, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT
6, d2drzB_, 0.9779, 0.67, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH LACTOSE
7, d2zqoB_, 0.9530, 1.15, 0.937, 130, 128, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH GALNAC
8, d2ao3A_, 0.9529, 1.17, 0.937, 130, 128,  
9, d2ao3B_, 0.9527, 1.15, 0.937, 130, 128,  
10, d2zqoA1, 0.9525, 1.40, 0.930, 130, 129, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH GALNAC
11, d2zqnA_, 0.9512, 1.20, 0.937, 131, 128, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH LACTOSE
12, d2d12A_, 0.9508, 1.20, 0.937, 130, 128,  
13, d2zqnB_, 0.9469, 1.50, 0.946, 131, 129, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH LACTOSE
14, d2d12B_, 0.9468, 1.50, 0.953, 130, 129,  
15, d2rstA1, 0.8925, 1.96, 0.953, 131, 129, NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF EW29
16, p3vszB2, 0.8475, 1.96, 0.953, 131, 129, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
17, p3vsfB2, 0.8475, 2.02, 0.185, 143, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
18, p3vt0B2, 0.8474, 2.02, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
19, p3vt2F2, 0.8473, 2.03, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
20, p3vt1B2, 0.8473, 2.03, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
21, p3vsfF2, 0.8468, 2.02, 0.185, 143, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
22, p3vt0F2, 0.8465, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
23, p3vszC1, 0.8464, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
24, p3vsfA2, 0.8463, 2.04, 0.185, 157, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
25, p3vszA2, 0.8462, 2.03, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
26, p3vt0A2, 0.8458, 2.02, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
27, p3vszF2, 0.8458, 2.03, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
28, p3vsfC1, 0.8456, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
29, p3vt2C1, 0.8454, 2.05, 0.185, 157, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
30, p3vt0C1, 0.8450, 2.05, 0.185, 157, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
31, p3vt1F2, 0.8449, 2.04, 0.185, 157, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
32, p3vt1A2, 0.8447, 2.05, 0.185, 157, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
33, p3vt2B2, 0.8446, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
34, p3vt1C1, 0.8445, 2.03, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
35, p3vszE2, 0.8443, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
36, p3vsfE2, 0.8441, 2.05, 0.185, 157, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
37, p3vt0E2, 0.8439, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
38, p3vt1E2, 0.8438, 2.05, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
39, p3vt2A2, 0.8435, 2.05, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
40, p3vt2E2, 0.8429, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
41, p3pg0A_, 0.8401, 2.04, 0.185, 143, 124, CRYSTAL STRUCTURE OF DESIGNED 3-FOLD SYMMETRIC PROTEIN THREEFOIL
42, p3vszD2, 0.8356, 2.05, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
43, p3vt0D2, 0.8353, 2.14, 0.153, 140, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
44, p3vsfD2, 0.8348, 2.14, 0.153, 140, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
45, p2x2sC_, 0.8328, 2.06, 0.185, 143, 124, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
46, p2x2tA_, 0.8245, 2.06, 0.185, 143, 124, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA IN COMPLEX WITH GAL-BETA13-GALNAC
47, p3vt1D2, 0.8237, 2.06, 0.185, 143, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
48, p2x2sD_, 0.8231, 2.63, 0.164, 148, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
49, p3vt2D2, 0.8220, 2.69, 0.164, 152, 128, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
50, p2x2sB_, 0.8209, 2.14, 0.185, 143, 124, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
51, p2x2sA_, 0.8191, 2.68, 0.164, 152, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
52, p2vlcA2, 0.8176, 2.19, 0.185, 143, 124, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
53, p2vlcB2, 0.8175, 2.72, 0.164, 152, 128, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
54, d1rzoB1, 0.8164, 2.72, 0.164, 152, 128, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
55, p5d61A1, 0.8151, 2.79, 0.164, 150, 128, MOA-Z-VAD-FMK COMPLEX DIRECT ORIENTATION
56, d2aaiB1, 0.8150, 2.17, 0.187, 131, 123, CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS
57, p5d62A1, 0.8147, 2.17, 0.187, 131, 123, MOA-Z-VAD-FMK COMPLEX INVERTED ORIENTATION
58, p5d63A1, 0.8145, 2.14, 0.197, 135, 122, MOA-Z-VAD-FMK INHIBITOR COMPLEX DIRECT/INVERTED DUAL ORIENTATION
59, d3rtiB1, 0.8139, 2.49, 0.157, 155, 127, CRYSTAL STRUCTURE OF RICIN BOUND WITH FORMYCIN MONOPHOSPHATE
60, d3rtjB1, 0.8136, 2.18, 0.172, 135, 122, CRYSTAL STRUCTURE OF RICIN BOUND WITH DINUCLEOTIDE APG
61, d2zr1B1, 0.8115, 2.49, 0.157, 170, 127, AGGLUTININ FROM ABRUS PRECATORIUS
62, d2zr1D1, 0.8111, 2.49, 0.157, 170, 127, AGGLUTININ FROM ABRUS PRECATORIUS
63, d2mllB1, 0.8111, 2.50, 0.157, 155, 127, MISTLETOE LECTIN I FROM VISCUM ALBUM
64, d1ce7B1, 0.8111, 2.17, 0.172, 135, 122, MISTLETOE LECTIN I FROM VISCUM ALBUM
65, d1pc8B1, 0.8110, 2.16, 0.172, 135, 122, CRYSTAL STRUCTURE OF A NOVEL FORM OF MISTLETOE LECTIN FROM HIMALAYAN VISCUM ALBUM L. AT 3.8A RESOLUTION
66, d2q3nB2, 0.8107, 2.15, 0.197, 136, 122, AGGLUTININ FROM ABRUS PRECATORIUS (APA-I)
67, d4jkxB1, 0.8105, 2.14, 0.197, 136, 122, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH KINETIN AT 2.35 A RESOLUTION.
68, d1isyB1, 0.8101, 2.30, 0.187, 133, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE
69, d1abrB1, 0.8100, 2.30, 0.187, 133, 123, CRYSTAL STRUCTURE OF ABRIN-A
70, p6elyB1, 0.8097, 2.25, 0.187, 133, 123, CRYSTAL STRUCTURE OF MISTLETOE LECTIN I (ML-I) FROM VISCUM ALBUM IN COMPLEX WITH 4-N-FURFURYLCYTOSINE AT 2.84 A RESOLUTION 
71, d1rzoD1, 0.8097, 2.13, 0.197, 134, 122, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
72, d2r9kB1, 0.8096, 2.29, 0.187, 137, 123, CRYSTAL STRUCTURE OF MISTELTOE LECTIN I IN COMPLEX WITH PHLORETAMIDE
73, d3o5wB1, 0.8095, 2.25, 0.190, 133, 121, BINDING OF KINETIN IN THE ACTIVE SITE OF MISTLETOE LECTIN I
74, d4eb2B1, 0.8094, 2.16, 0.189, 140, 122, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE AT 1.94 A RESOLUTION.
75, d1m2tB1, 0.8092, 2.16, 0.189, 140, 122, MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH ADENINE MONOPHOSPHATE. CRYSTAL STRUCTURE AT 1.9 A RESOLUTION
76, d3d7wB1, 0.8090, 2.29, 0.187, 139, 123, MISTLETOE LECTIN I IN COMPLEX WITH ZEATIN
77, d1onkB1, 0.8090, 2.20, 0.197, 135, 122, MISTLETOE LECTIN I FROM VISCUM ALBUM
78, d3cefB1, 0.8089, 2.29, 0.187, 136, 123,  
79, d1v6uB1, 0.8089, 2.28, 0.187, 136, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L- ARABINOFURANOSYL-XYLOBIOSE
80, d1oqlB1, 0.8087, 2.30, 0.187, 137, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM COMPLEXED WITH GALACTOSE
81, d1v6wB1, 0.8086, 2.30, 0.187, 136, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOBIOSE
82, d1pumB1, 0.8086, 2.30, 0.187, 136, 123, MISTLETOE LECTIN I IN COMPLEX WITH GALACTOSE
83, d3c9zA1, 0.8085, 2.30, 0.179, 137, 123, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) TETRAGONAL CRYSTAL FORM
84, d2rg9B1, 0.8085, 2.30, 0.187, 136, 123, CRYSTAL STRUCTURE OF VISCUM ALBUM MISTLETOE LECTIN I IN NATIVE STATE AT 1.95 A RESOLUTION COMPARISON OF STRUCTURE ACTIVE SITE CONFORMATION IN RICIN AND IN VISCUMIN
85, d5mu9A1, 0.8084, 2.26, 0.190, 133, 121, MOA-E-64 COMPLEX
86, p2vsaA2, 0.8082, 2.30, 0.187, 137, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
87, d1sz6B1, 0.8082, 2.26, 0.190, 133, 121, MISTLETOE LECTIN I FROM VISCUM ALBUM. CRYSTAL STRUCTURE AT 2.05 A RESOLUTION
88, d1puuB3, 0.8082, 2.30, 0.187, 137, 123, MISTLETOE LECTIN I IN COMPLEX WITH LACTOSE
89, d1tfmB1, 0.8081, 2.18, 0.165, 128, 121, CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM
90, d1v6xB1, 0.8078, 2.31, 0.187, 137, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOTRIOSE
91, d1iswA1, 0.8077, 2.50, 0.159, 154, 126, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE
92, d3ca4A1, 0.8076, 2.08, 0.148, 146, 122, SAMBUCUS NIGRA AGGLUTININ II TETRAGONAL CRYSTAL FORM- COMPLEXED TO LACTOSE
93, p2vseA2, 0.8076, 2.08, 0.148, 146, 122, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
94, d3cahA1, 0.8075, 2.31, 0.187, 137, 123, SAMBUCUS NIGRA AGGUTININ II. TETRAGONAL CRYSTAL FORM- COMPLEXED TO FUCOSE
95, p2vseB2, 0.8075, 2.31, 0.187, 138, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
96, d1isvA1, 0.8075, 2.31, 0.179, 133, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE
97, d3ef2A1, 0.8073, 2.25, 0.190, 133, 121, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
98, d1v6vB1, 0.8073, 2.28, 0.190, 133, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L- ARABINOFURANOSYL-XYLOTRIOSE
99, d3ef2B1, 0.8072, 2.17, 0.165, 128, 121, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
100, d1hwmB2, 0.8072, 2.26, 0.146, 146, 123, EBULINORTHORHOMBIC CRYSTAL FORM MODEL
101, d3ef2D1, 0.8070, 2.17, 0.165, 128, 121, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
102, d3ca3A1, 0.8070, 2.27, 0.146, 146, 123, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO N-ACETYLGALACTOSAMINE
103, d3ef2C1, 0.8066, 2.28, 0.190, 133, 121, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
104, d1knmA_, 0.8066, 2.28, 0.190, 133, 121, STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH LACTOSE
105, d1v6vA1, 0.8065, 2.51, 0.159, 154, 126, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L- ARABINOFURANOSYL-XYLOTRIOSE
106, d1isxA1, 0.8065, 2.27, 0.190, 133, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE
107, d3ca1A1, 0.8063, 2.50, 0.159, 154, 126, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO GALACTOSE
108, d3ca0A1, 0.8063, 1.85, 0.175, 131, 120, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) HEXAGONAL CRYSTAL FORM
109, d1v6wA1, 0.8063, 1.85, 0.175, 131, 120, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOBIOSE
110, d1isxB1, 0.8063, 2.51, 0.159, 154, 126, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE
111, d1iswB1, 0.8062, 2.18, 0.165, 128, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE
112, d1isvB1, 0.8061, 2.51, 0.159, 154, 126, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE
113, d1v6xA1, 0.8060, 2.20, 0.190, 129, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOTRIOSE
114, d1yf8B1, 0.8058, 2.26, 0.190, 133, 121, CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE
115, d3ca6A1, 0.8055, 2.28, 0.190, 133, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO TN ANTIGEN
116, d3ca5A1, 0.8055, 2.18, 0.165, 128, 121, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO ALPHA1 METHYLGALACTOSE
117, d1hwmB1, 0.8051, 2.19, 0.165, 128, 121, EBULINORTHORHOMBIC CRYSTAL FORM MODEL
118, d5gqeA2, 0.8050, 2.29, 0.190, 133, 121, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
119, p4lo7F2, 0.8046, 2.25, 0.190, 133, 121, HA70(D3)-HA17-HA33
120, p4lo7B2, 0.8046, 2.30, 0.190, 133, 121, HA70(D3)-HA17-HA33
121, d4lo0A2, 0.8046, 2.27, 0.190, 133, 121, APO HA17-HA33
122, d4lo1A2, 0.8045, 2.29, 0.190, 133, 121, HA17-HA33-GAL
123, d4lo2A2, 0.8044, 2.33, 0.179, 133, 123, HA17-HA33-LAC
124, d4qd2I2, 0.8043, 2.19, 0.165, 128, 121, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
125, d4hr6C1, 0.8043, 2.18, 0.165, 128, 121, CRYSTAL STRUCTURE OF SNAKE GOURD (TRICHOSANTHES ANGUINA) SEED LECTIN A THREE CHAIN HOMOLOGUE OF TYPE II RIPS
126, d2ihoA1, 0.8042, 2.11, 0.175, 133, 120, CRYSTAL STRUCTURE OF MOA A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(13)GAL(14)GLCNAC
127, p4g9mA_, 0.8040, 2.19, 0.192, 126, 120, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
128, d4lo3A2, 0.8039, 2.33, 0.187, 145, 123, HA17-HA33-LACNAC
129, d1v6uA1, 0.8037, 2.33, 0.187, 145, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L- ARABINOFURANOSYL-XYLOBIOSE
130, d4lo1B2, 0.8035, 2.33, 0.187, 145, 123, HA17-HA33-GAL
131, d1isyA1, 0.8035, 2.33, 0.187, 142, 123, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE
132, d3aj5B2, 0.8033, 2.33, 0.187, 142, 123, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
133, d3ah2A2, 0.8033, 2.33, 0.187, 142, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
134, d5bp5A2, 0.8031, 2.33, 0.179, 142, 123, CRYSTAL STRUCTURE OF HA17-HA33-IPT
135, d2ehmA4, 0.8031, 2.12, 0.198, 133, 121,  
136, d1qxmA2, 0.8029, 2.12, 0.198, 133, 121, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
137, d2ehnA4, 0.8028, 2.54, 0.159, 154, 126,  
138, d4lo2B2, 0.8027, 2.23, 0.165, 142, 121, HA17-HA33-LAC
139, d3ah4A2, 0.8027, 2.34, 0.187, 142, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
140, d3ah4B2, 0.8025, 2.33, 0.190, 133, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
141, d3ah2B2, 0.8025, 2.33, 0.187, 142, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
142, d2ehnB4, 0.8025, 2.32, 0.190, 133, 121,  
143, d2e4mB2, 0.8025, 2.24, 0.207, 138, 121, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
144, d5bp5B2, 0.8024, 2.22, 0.207, 138, 121, CRYSTAL STRUCTURE OF HA17-HA33-IPT
145, d3ah1A2, 0.8024, 2.35, 0.187, 142, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
146, d2ehiB4, 0.8024, 2.22, 0.207, 138, 121,  
147, d1ybiA2, 0.8024, 2.21, 0.207, 138, 121, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
148, d4qd2H2, 0.8023, 2.21, 0.207, 138, 121, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
149, d3ah1B2, 0.8023, 2.21, 0.207, 138, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
150, d5gqeB2, 0.8022, 2.32, 0.187, 142, 123, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
151, d2ehmB4, 0.8020, 2.21, 0.207, 138, 121,  
152, d2ehiA4, 0.8020, 2.23, 0.207, 138, 121,  
153, d4oujA2, 0.8019, 2.24, 0.207, 138, 121, CRYSTAL STRUCTURE OF HA33B-LAC
154, p4g9nA_, 0.8018, 2.23, 0.207, 138, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
155, d3aj5A2, 0.8018, 2.24, 0.207, 138, 121, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
156, d1qxmB2, 0.8018, 2.34, 0.187, 142, 123, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
157, p4g9mB_, 0.8017, 2.23, 0.207, 138, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
158, d3aj6B2, 0.8016, 2.24, 0.207, 138, 121, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
159, d3aj6A2, 0.8016, 2.36, 0.187, 142, 123, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
160, d4oujB2, 0.8015, 2.35, 0.187, 142, 123, CRYSTAL STRUCTURE OF HA33B-LAC
161, d1knlA_, 0.8014, 2.24, 0.207, 138, 121, STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13
162, d1hwnB1, 0.8014, 2.19, 0.192, 126, 120, EBULIN COMPLEXED WITH GALACTOSE TRIGONAL CRYSTAL FORM
163, d1hwoB1, 0.8013, 2.24, 0.207, 138, 121, EBULIN COMPLEXED WITH LACTOSE TRIGONAL CRYSTAL FORM
164, p5vbkB_, 0.8009, 2.22, 0.207, 138, 121, CRYSTAL STRUCTURE OF A GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS
165, p3nbeB_, 0.8007, 2.39, 0.203, 138, 123, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
166, d1hwpB1, 0.8006, 2.25, 0.165, 142, 121, EBULIN COMPLEXED WITH PTEROIC ACID TRIGONAL CRYSTAL FORM
167, d2e4mA2, 0.7999, 2.23, 0.207, 138, 121, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
168, p4lo7H2, 0.7998, 2.24, 0.207, 138, 121, HA70(D3)-HA17-HA33
169, p4lo7D2, 0.7998, 2.26, 0.165, 143, 121, HA70(D3)-HA17-HA33
170, d4lo0B2, 0.7998, 2.26, 0.165, 143, 121, APO HA17-HA33
171, d1mc9A_, 0.7994, 2.24, 0.207, 138, 121, STREPROMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH XYLOPENTAOSE
172, p4g9nB_, 0.7993, 2.23, 0.207, 138, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
173, p3a22B4, 0.7993, 2.39, 0.203, 138, 123, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH L- ARABINOSE
174, d5bquA2, 0.7992, 2.22, 0.183, 126, 120, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
175, p3a23B4, 0.7980, 2.12, 0.175, 134, 120, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH D- GALACTOSE
176, d5gqdA2, 0.7974, 2.12, 0.175, 134, 120, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E- 86
177, p5f90A_, 0.7972, 2.21, 0.165, 134, 121, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GB3 ALLYL
178, d3ca0A2, 0.7971, 2.05, 0.134, 150, 119, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) HEXAGONAL CRYSTAL FORM
179, d5b2hA2, 0.7970, 2.31, 0.180, 147, 122, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
180, p3nbeA_, 0.7970, 2.20, 0.165, 134, 121, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
181, d1ybiB2, 0.7970, 2.25, 0.207, 138, 121, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
182, p5duyC_, 0.7966, 2.37, 0.187, 145, 123, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
183, d4qd2D2, 0.7965, 2.37, 0.187, 145, 123, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
184, d1hwpB2, 0.7963, 2.37, 0.187, 142, 123, EBULIN COMPLEXED WITH PTEROIC ACID TRIGONAL CRYSTAL FORM
185, p3wmvA_, 0.7960, 2.25, 0.183, 126, 120, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC WITH LIGAND FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
186, d1it0A1, 0.7958, 2.28, 0.165, 143, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE
187, p5duyE_, 0.7957, 2.16, 0.168, 127, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
188, p5duyA_, 0.7954, 2.38, 0.187, 142, 123, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
189, d3ca6A2, 0.7953, 2.18, 0.168, 127, 119, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO TN ANTIGEN
190, d3ca3A2, 0.7953, 1.97, 0.197, 124, 117, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO N-ACETYLGALACTOSAMINE
191, d1hwnB2, 0.7953, 2.08, 0.143, 150, 119, EBULIN COMPLEXED WITH GALACTOSE TRIGONAL CRYSTAL FORM
192, p5duyB_, 0.7952, 1.83, 0.161, 129, 118, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
193, d3c9zA2, 0.7952, 2.29, 0.207, 137, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) TETRAGONAL CRYSTAL FORM
194, d4oujB1, 0.7949, 2.29, 0.207, 137, 121, CRYSTAL STRUCTURE OF HA33B-LAC
195, d3cahA2, 0.7949, 2.33, 0.180, 147, 122, SAMBUCUS NIGRA AGGUTININ II. TETRAGONAL CRYSTAL FORM- COMPLEXED TO FUCOSE
196, p3wmuA_, 0.7947, 2.41, 0.187, 142, 123, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC APO-FORM FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
197, d3ca4A2, 0.7947, 2.08, 0.134, 150, 119, SAMBUCUS NIGRA AGGLUTININ II TETRAGONAL CRYSTAL FORM- COMPLEXED TO LACTOSE
198, p5xg5A_, 0.7946, 2.42, 0.179, 142, 123, CRYSTAL STRUCTURE OF MITSUBA-1 WITH BOUND NACGAL
199, d4oujA1, 0.7946, 1.98, 0.160, 129, 119, CRYSTAL STRUCTURE OF HA33B-LAC
200, d3ca1A2, 0.7945, 2.10, 0.134, 150, 119, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO GALACTOSE
201, d1hwoB2, 0.7945, 2.16, 0.195, 124, 118, EBULIN COMPLEXED WITH LACTOSE TRIGONAL CRYSTAL FORM
202, d1xyfA1, 0.7944, 2.09, 0.143, 150, 119, ENDO-14-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS
203, d4lo3B2, 0.7943, 2.09, 0.134, 150, 119, HA17-HA33-LACNAC
204, d3ca5A2, 0.7942, 1.85, 0.161, 129, 118, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO ALPHA1 METHYLGALACTOSE
205, p3a21B4, 0.7942, 1.86, 0.161, 129, 118, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS BETA-L- ARABINOPYRANOSIDASE
206, d1iszA1, 0.7942, 1.86, 0.161, 129, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE
207, p5duyF_, 0.7941, 2.09, 0.134, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
208, p3a23A3, 0.7941, 1.85, 0.161, 129, 118, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH D- GALACTOSE
209, p3a22A3, 0.7941, 1.82, 0.161, 143, 118, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH L- ARABINOSE
210, d5b2hB2, 0.7940, 1.86, 0.161, 129, 118, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
211, d5gqdB2, 0.7937, 2.10, 0.134, 151, 119, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E- 86
212, p3wmuB_, 0.7937, 1.85, 0.161, 129, 118, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC APO-FORM FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
213, p3wmvB_, 0.7933, 2.18, 0.100, 145, 120, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC WITH LIGAND FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
214, p3a21A3, 0.7933, 1.83, 0.161, 143, 118, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS BETA-L- ARABINOPYRANOSIDASE
215, d1iszB1, 0.7931, 1.86, 0.161, 129, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE
216, d1xyfB1, 0.7929, 1.99, 0.160, 129, 119, ENDO-14-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS
217, p5vbkA_, 0.7926, 2.18, 0.195, 124, 118, CRYSTAL STRUCTURE OF A GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS
218, p4owlE_, 0.7926, 2.42, 0.187, 142, 123, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
219, p5f8yB_, 0.7922, 1.86, 0.161, 129, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
220, p4owjB_, 0.7922, 2.20, 0.168, 127, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
221, d1it0B1, 0.7922, 2.17, 0.195, 124, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE
222, p4owlC_, 0.7920, 2.11, 0.134, 150, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
223, p4owkE_, 0.7920, 2.22, 0.168, 127, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
224, p4owjG_, 0.7920, 2.22, 0.168, 127, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
225, p4owkA_, 0.7918, 2.31, 0.207, 137, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
226, p4owlD_, 0.7917, 2.18, 0.195, 124, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
227, p4owjC_, 0.7917, 2.13, 0.134, 153, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
228, p3winB1, 0.7917, 2.13, 0.134, 153, 119, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
229, p5f8sB_, 0.7916, 2.06, 0.136, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
230, p4owkD_, 0.7916, 2.22, 0.168, 127, 119, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
231, p4owjF_, 0.7916, 2.19, 0.195, 124, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
232, p4owkF_, 0.7915, 2.19, 0.195, 124, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
233, p5f8yA_, 0.7914, 2.10, 0.134, 150, 119, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
234, p5f8sA_, 0.7914, 2.19, 0.149, 132, 121, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
235, p5f90B_, 0.7913, 2.06, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GB3 ALLYL
236, p4owkG_, 0.7912, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
237, p4jp0A1, 0.7912, 2.20, 0.195, 124, 118, CRYSTAL STRUCTURE OF CRY35AB1
238, p5duyD_, 0.7911, 2.20, 0.149, 131, 121, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
239, p4owlG_, 0.7911, 2.20, 0.149, 136, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
240, p5f8wA_, 0.7910, 2.19, 0.149, 131, 121, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
241, p3winA1, 0.7910, 2.18, 0.149, 131, 121, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
242, p5f8wB_, 0.7909, 2.20, 0.149, 137, 121, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
243, d1ggpB2, 0.7904, 2.20, 0.149, 137, 121, CRYSTAL STRUCTURE OF TRICHOSANTHES KIRILOWII LECTIN-1 AND ITS RELATION TO THE TYPE 2 RIBOSOME INACTIVATING PROTEINS
244, p4owlA_, 0.7903, 2.19, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
245, p4owlF_, 0.7901, 1.83, 0.161, 143, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
246, p4owjD_, 0.7900, 2.06, 0.136, 149, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
247, p4owlB_, 0.7899, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
248, p4owkC_, 0.7896, 2.20, 0.149, 132, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
249, p4iy9B2, 0.7895, 2.20, 0.149, 133, 121, BMLP3 - C2 CRYSTAL FORM
250, p3winB2, 0.7895, 2.08, 0.144, 149, 118, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
251, p3nbdB_, 0.7888, 2.07, 0.144, 149, 118, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
252, d4zfyB2, 0.7884, 2.07, 0.144, 149, 118, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH ALPHA-METHYL-D- GALACTOSIDE
253, d4hr6C2, 0.7881, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF SNAKE GOURD (TRICHOSANTHES ANGUINA) SEED LECTIN A THREE CHAIN HOMOLOGUE OF TYPE II RIPS
254, d4zgrB1, 0.7872, 2.29, 0.174, 143, 121, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.
255, p3nbdA_, 0.7869, 2.29, 0.174, 143, 121, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
256, d2e4mA1, 0.7868, 2.07, 0.144, 149, 118, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
257, d2ehmB3, 0.7867, 2.22, 0.149, 131, 121,  
258, d3aj6A1, 0.7866, 2.08, 0.144, 149, 118, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
259, d3aj5B1, 0.7866, 1.86, 0.161, 143, 118, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
260, d3ah2B1, 0.7866, 1.86, 0.161, 143, 118, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
261, d1qxmA1, 0.7865, 2.08, 0.144, 149, 118, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
262, d3ah1B1, 0.7864, 1.97, 0.186, 128, 118, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
263, d4zgrB2, 0.7862, 1.97, 0.186, 128, 118, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.
264, d4zfwB2, 0.7862, 2.21, 0.149, 132, 121, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH GALACTOSE.
265, d4z8sB2, 0.7861, 2.19, 0.149, 131, 121, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-1
266, p2vseA3, 0.7860, 2.20, 0.149, 131, 121, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
267, p3winA2, 0.7859, 2.21, 0.149, 131, 121, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
268, d2ehnB3, 0.7859, 2.22, 0.149, 131, 121,  
269, d4zfuB2, 0.7858, 2.28, 0.081, 157, 124, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE
270, d4za3B2, 0.7857, 2.48, 0.187, 143, 123, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-3
271, d1ggpB1, 0.7857, 2.37, 0.172, 148, 122, CRYSTAL STRUCTURE OF TRICHOSANTHES KIRILOWII LECTIN-1 AND ITS RELATION TO THE TYPE 2 RIBOSOME INACTIVATING PROTEINS
272, d4zfwB1, 0.7856, 1.87, 0.188, 129, 117, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH GALACTOSE.
273, d3ah4B1, 0.7856, 1.97, 0.186, 131, 118, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
274, d4zlbB2, 0.7855, 1.97, 0.186, 131, 118, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH LACTOSE
275, d4z8sB1, 0.7855, 2.10, 0.212, 132, 118, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-1
276, p2vseB3, 0.7855, 2.38, 0.172, 148, 122, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
277, d4zbvB2, 0.7854, 1.77, 0.172, 147, 116, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH BENZYL T-ANTIGEN
278, d2ehnA3, 0.7854, 1.78, 0.181, 145, 116,  
279, d1qxmB1, 0.7854, 1.76, 0.181, 145, 116, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
280, d4zbvB1, 0.7853, 1.78, 0.181, 145, 116, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH BENZYL T-ANTIGEN
281, p4iy8D2, 0.7853, 1.78, 0.181, 145, 116, BMLP3 - P21 CRYSTAL FORM
282, d3aj5A1, 0.7853, 1.77, 0.181, 145, 116, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
283, d3ah4A1, 0.7853, 1.77, 0.181, 148, 116, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
284, d5b2hB1, 0.7850, 1.89, 0.188, 129, 117, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
285, d3ah2A1, 0.7849, 1.88, 0.188, 129, 117, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
286, d2ehiB3, 0.7846, 1.88, 0.188, 129, 117,  
287, p5nqaB2, 0.7844, 2.29, 0.218, 141, 119, CRYSTAL STRUCTURE OF GALNAC-T4 IN COMPLEX WITH THE MONOGLYCOPEPTIDE 3
288, d4zfuB1, 0.7844, 2.49, 0.187, 143, 123, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE
289, d2ehmA3, 0.7844, 1.79, 0.181, 147, 116,  
290, d4qd2I1, 0.7843, 1.89, 0.188, 129, 117, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
291, p4iy8A2, 0.7841, 1.89, 0.188, 129, 117, BMLP3 - P21 CRYSTAL FORM
292, d3aj6B1, 0.7839, 2.17, 0.176, 126, 119, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
293, d5b2hA1, 0.7836, 2.11, 0.212, 132, 118, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
294, d4z9wB2, 0.7833, 1.79, 0.181, 147, 116, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-2
295, d4zfyB1, 0.7829, 1.89, 0.188, 129, 117, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH ALPHA-METHYL-D- GALACTOSIDE
296, d4z9wB1, 0.7828, 2.10, 0.212, 132, 118, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-2
297, d4zlbB1, 0.7826, 2.29, 0.218, 141, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH LACTOSE
298, p3nbcB_, 0.7826, 1.89, 0.188, 129, 117, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
299, p5nqaA2, 0.7825, 1.78, 0.181, 145, 116, CRYSTAL STRUCTURE OF GALNAC-T4 IN COMPLEX WITH THE MONOGLYCOPEPTIDE 3
300, p3nbcA_, 0.7825, 1.80, 0.181, 145, 116, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
301, p4iy8C2, 0.7824, 2.13, 0.212, 132, 118, BMLP3 - P21 CRYSTAL FORM
302, d2e4mB1, 0.7824, 2.36, 0.081, 157, 124, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
303, d4qd2D1, 0.7820, 1.78, 0.181, 145, 116, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
304, d4qd2C1, 0.7819, 1.78, 0.181, 145, 116, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
305, p4owjE_, 0.7818, 1.79, 0.181, 146, 116, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
306, p2vsaA3, 0.7817, 1.79, 0.181, 145, 116, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
307, d4za3B1, 0.7812, 1.79, 0.190, 148, 116, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-3
308, p4owjA_, 0.7811, 1.79, 0.190, 148, 116, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
309, d4qd2H1, 0.7808, 2.41, 0.152, 143, 125, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
310, p3pubB2, 0.7806, 2.12, 0.212, 132, 118, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
311, d5bp5B1, 0.7805, 1.79, 0.181, 145, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
312, p4iy8B2, 0.7804, 1.79, 0.164, 143, 116, BMLP3 - P21 CRYSTAL FORM
313, p6elyB2, 0.7803, 2.41, 0.081, 157, 124, CRYSTAL STRUCTURE OF MISTLETOE LECTIN I (ML-I) FROM VISCUM ALBUM IN COMPLEX WITH 4-N-FURFURYLCYTOSINE AT 2.84 A RESOLUTION 
314, d1ybiB1, 0.7801, 1.81, 0.181, 146, 116, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
315, d4lo2B1, 0.7800, 1.81, 0.181, 146, 116, HA17-HA33-LAC
316, d4lo1B1, 0.7797, 1.90, 0.188, 129, 117, HA17-HA33-GAL
317, d1abrB2, 0.7797, 2.11, 0.212, 132, 118, CRYSTAL STRUCTURE OF ABRIN-A
318, d5bquB1, 0.7796, 2.17, 0.212, 132, 118, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
319, p4owkB_, 0.7796, 2.15, 0.212, 132, 118, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
320, d4lo3B1, 0.7795, 2.41, 0.172, 148, 122, HA17-HA33-LACNAC
321, p3pubA2, 0.7795, 2.44, 0.160, 143, 125, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
322, p4lo7H1, 0.7794, 2.44, 0.160, 143, 125, HA70(D3)-HA17-HA33
323, p4lo7D1, 0.7794, 2.42, 0.172, 148, 122, HA70(D3)-HA17-HA33
324, d4lo0B1, 0.7794, 2.42, 0.172, 148, 122, APO HA17-HA33
325, p4lo7F1, 0.7792, 2.34, 0.081, 157, 124, HA70(D3)-HA17-HA33
326, p4lo7B1, 0.7792, 1.81, 0.172, 147, 116, HA70(D3)-HA17-HA33
327, d4lo0A1, 0.7792, 1.82, 0.164, 143, 116, APO HA17-HA33
328, p2vsaA4, 0.7789, 1.80, 0.172, 143, 116, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
329, d4lo1A1, 0.7787, 2.30, 0.149, 131, 121, HA17-HA33-GAL
330, p4iy9A2, 0.7784, 2.33, 0.210, 141, 119, BMLP3 - C2 CRYSTAL FORM
331, d5bp5A1, 0.7783, 2.33, 0.210, 141, 119, CRYSTAL STRUCTURE OF HA17-HA33-IPT
332, d4lo3A1, 0.7782, 2.20, 0.212, 131, 118, HA17-HA33-LACNAC
333, d4lo2A1, 0.7781, 2.29, 0.149, 131, 121, HA17-HA33-LAC
334, d5bquA1, 0.7780, 1.81, 0.164, 143, 116, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
335, d3ah1A1, 0.7780, 2.34, 0.081, 158, 123, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
336, p4pc4C2, 0.7778, 2.34, 0.081, 158, 123, BOMBYX MORI LIPOPROTEIN 6
337, p4pc4A2, 0.7778, 1.82, 0.172, 142, 116, BOMBYX MORI LIPOPROTEIN 6
338, d2rg9B2, 0.7778, 2.44, 0.081, 157, 124, CRYSTAL STRUCTURE OF VISCUM ALBUM MISTLETOE LECTIN I IN NATIVE STATE AT 1.95 A RESOLUTION COMPARISON OF STRUCTURE ACTIVE SITE CONFORMATION IN RICIN AND IN VISCUMIN
339, p4pc4D2, 0.7777, 2.02, 0.197, 124, 117, BOMBYX MORI LIPOPROTEIN 6
340, p4pc4E2, 0.7772, 1.82, 0.164, 142, 116, BOMBYX MORI LIPOPROTEIN 6
341, d1sz6B2, 0.7769, 1.83, 0.172, 143, 116, MISTLETOE LECTIN I FROM VISCUM ALBUM. CRYSTAL STRUCTURE AT 2.05 A RESOLUTION
342, d4eb2B2, 0.7768, 1.83, 0.172, 142, 116, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE AT 1.94 A RESOLUTION.
343, d3o5wB2, 0.7764, 1.83, 0.217, 127, 115, BINDING OF KINETIN IN THE ACTIVE SITE OF MISTLETOE LECTIN I
344, p2vseA4, 0.7761, 1.83, 0.172, 142, 116, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
345, p4pc4B2, 0.7759, 2.33, 0.149, 131, 121, BOMBYX MORI LIPOPROTEIN 6
346, p2vseB4, 0.7754, 1.84, 0.172, 142, 116, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
347, p5ehaA_, 0.7752, 2.46, 0.073, 157, 124, CRYSTAL STRUCTURE OF RECOMBINANT MTAL AT 1.35 ANGSTROM RESOLUTION
348, d1rzoB2, 0.7749, 1.84, 0.172, 141, 116, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
349, d4jkxB2, 0.7748, 1.84, 0.172, 141, 116, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH KINETIN AT 2.35 A RESOLUTION.
350, d2ehiA3, 0.7748, 1.84, 0.172, 142, 116,  
351, d1ybiA1, 0.7744, 1.85, 0.172, 141, 116, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
352, d1onkB2, 0.7742, 1.85, 0.172, 141, 116, MISTLETOE LECTIN I FROM VISCUM ALBUM
353, d1pumB2, 0.7740, 1.85, 0.172, 143, 116, MISTLETOE LECTIN I IN COMPLEX WITH GALACTOSE
354, d2r9kB2, 0.7736, 2.35, 0.168, 144, 119, CRYSTAL STRUCTURE OF MISTELTOE LECTIN I IN COMPLEX WITH PHLORETAMIDE
355, d2f2fA1, 0.7733, 2.35, 0.168, 144, 119, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
356, d2f2fD_, 0.7730, 1.85, 0.172, 143, 116, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
357, d1m2tB2, 0.7729, 2.44, 0.081, 157, 124, MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH ADENINE MONOPHOSPHATE. CRYSTAL STRUCTURE AT 1.9 A RESOLUTION
358, d3cefB2, 0.7728, 1.86, 0.172, 143, 116,  
359, p4efqA2, 0.7727, 1.86, 0.172, 143, 116, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
360, d1puuB4, 0.7726, 1.87, 0.172, 143, 116, MISTLETOE LECTIN I IN COMPLEX WITH LACTOSE
361, d3phzB1, 0.7724, 1.87, 0.172, 142, 116, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
362, p4efqB2, 0.7723, 1.85, 0.190, 145, 116, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
363, d5bquB2, 0.7722, 2.49, 0.097, 159, 124, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
364, d1oqlB2, 0.7720, 2.50, 0.097, 159, 124, MISTLETOE LECTIN I FROM VISCUM ALBUM COMPLEXED WITH GALACTOSE
365, d3d7wB2, 0.7719, 2.50, 0.097, 159, 124, MISTLETOE LECTIN I IN COMPLEX WITH ZEATIN
366, d1rzoD2, 0.7719, 2.04, 0.171, 126, 117, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
367, d3w9tD2, 0.7716, 2.50, 0.097, 159, 124, PORE-FORMING CEL-III
368, d3w9tF2, 0.7715, 2.52, 0.097, 159, 124, PORE-FORMING CEL-III
369, d3w9tC2, 0.7714, 2.06, 0.188, 126, 117, PORE-FORMING CEL-III
370, d3w9tB2, 0.7714, 1.79, 0.191, 126, 115, PORE-FORMING CEL-III
371, d3w9tA2, 0.7714, 1.81, 0.165, 126, 115, PORE-FORMING CEL-III
372, d3w9tG2, 0.7712, 2.37, 0.168, 144, 119, PORE-FORMING CEL-III
373, d3w9tE2, 0.7712, 2.50, 0.097, 159, 124, PORE-FORMING CEL-III
374, p4efpA2, 0.7709, 2.38, 0.168, 144, 119, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
375, p2ffuA2, 0.7709, 2.16, 0.133, 153, 120, CRYSTAL STRUCTURE OF HUMAN PPGALNACT-2 COMPLEXED WITH UDP AND EA2
376, d1pc8B2, 0.7709, 2.16, 0.133, 153, 120, CRYSTAL STRUCTURE OF A NOVEL FORM OF MISTLETOE LECTIN FROM HIMALAYAN VISCUM ALBUM L. AT 3.8A RESOLUTION
377, p4efrC2, 0.7708, 1.87, 0.217, 127, 115, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
378, d3phzA1, 0.7706, 1.87, 0.217, 127, 115, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
379, d1upsB2, 0.7705, 1.82, 0.165, 126, 115, GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS
380, p4uspA_, 0.7704, 1.89, 0.190, 145, 116, X-RAY STRUCTURE OF THE DIMERIC CCL2 LECTIN IN NATIVE FORM
381, p4efrA2, 0.7704, 1.88, 0.164, 142, 116, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
382, p4izxA_, 0.7703, 2.19, 0.169, 126, 118, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH LACTOSE
383, p4iybB_, 0.7702, 1.85, 0.191, 126, 115, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
384, p2vseB5, 0.7702, 2.22, 0.162, 126, 117, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
385, p4usoB_, 0.7701, 2.87, 0.095, 153, 126, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
386, p4j2sA_, 0.7700, 2.87, 0.095, 153, 126, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH DI- LACNAC
387, p2vseA5, 0.7700, 1.86, 0.165, 126, 115, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
388, p4uspB_, 0.7699, 1.84, 0.165, 126, 115, X-RAY STRUCTURE OF THE DIMERIC CCL2 LECTIN IN NATIVE FORM
389, p4efpB2, 0.7699, 2.37, 0.074, 156, 122, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
390, p4usoA_, 0.7697, 1.87, 0.183, 125, 115, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
391, d2z49B2, 0.7694, 2.31, 0.144, 140, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
392, p2vsaA5, 0.7691, 2.47, 0.065, 156, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
393, d1upsA2, 0.7691, 2.18, 0.195, 134, 118, GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS
394, d2z49A2, 0.7688, 1.88, 0.174, 126, 115, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
395, p4ionB_, 0.7687, 2.22, 0.162, 126, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
396, d3rtjB2, 0.7682, 1.98, 0.216, 127, 116, CRYSTAL STRUCTURE OF RICIN BOUND WITH DINUCLEOTIDE APG
397, d1vclA2, 0.7682, 2.12, 0.145, 133, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
398, d1yf8B2, 0.7677, 2.12, 0.145, 133, 117, CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE
399, d5muaB1, 0.7675, 2.12, 0.145, 133, 117, PSL1A-E64 COMPLEX
400, d1vclB2, 0.7675, 2.12, 0.145, 133, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
401, d2zr1B2, 0.7669, 2.12, 0.145, 133, 117, AGGLUTININ FROM ABRUS PRECATORIUS
402, d1tfmB2, 0.7668, 2.12, 0.145, 133, 117, CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM
403, p4iybA_, 0.7663, 2.12, 0.145, 133, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
404, p4efrB2, 0.7662, 2.40, 0.074, 156, 122, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
405, p2y9wD_, 0.7660, 2.01, 0.111, 125, 117, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
406, p4ionA_, 0.7659, 1.81, 0.175, 122, 114, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
407, p5g37A2, 0.7658, 2.38, 0.074, 156, 122, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
408, d2zr1D2, 0.7656, 2.29, 0.144, 140, 118, AGGLUTININ FROM ABRUS PRECATORIUS
409, p2y9wC_, 0.7656, 2.29, 0.144, 140, 118, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
410, d2q3nB1, 0.7653, 2.26, 0.101, 131, 119, AGGLUTININ FROM ABRUS PRECATORIUS (APA-I)
411, d2z48A2, 0.7652, 2.11, 0.112, 135, 116, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
412, p2d7rA2, 0.7650, 2.37, 0.074, 156, 122, CRYSTAL STRUCTURE OF PP-GALNAC-T10 COMPLEXED WITH GALNAC-SER ON LECTIN DOMAIN
413, p4efrD2, 0.7647, 2.30, 0.171, 139, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
414, d2z48B2, 0.7646, 2.30, 0.171, 140, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
415, p2d7iA2, 0.7645, 2.47, 0.182, 140, 121, CRSYTAL STRUCTURE OF PP-GALNAC-T10 WITH UDP GALNAC AND MN2+
416, d1vclB1, 0.7643, 2.12, 0.112, 135, 116, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
417, d1vclA1, 0.7639, 2.30, 0.171, 139, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
418, p5ajpA2, 0.7638, 2.47, 0.182, 140, 121, CRYSTAL STRUCTURE OF THE ACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH UDP AND THE GLYCOPEPTIDE MUC5AC-13
419, d3w9tF1, 0.7637, 2.11, 0.112, 135, 116, PORE-FORMING CEL-III
420, d2mllB2, 0.7637, 2.50, 0.065, 156, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM
421, d1ce7B2, 0.7637, 2.13, 0.112, 136, 116, MISTLETOE LECTIN I FROM VISCUM ALBUM
422, d2z49A1, 0.7635, 2.18, 0.145, 133, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
423, p2vlcA3, 0.7635, 2.47, 0.182, 140, 121, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
424, d1sr4A_, 0.7635, 2.47, 0.182, 140, 121, CRYSTAL STRUCTURE OF THE HAEMOPHILUS DUCREYI CYTOLETHAL DISTENDING TOXIN
425, p2y9xF_, 0.7634, 2.27, 0.101, 131, 119, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
426, p5fozA2, 0.7631, 2.27, 0.101, 131, 119, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
427, p2y9xE_, 0.7631, 2.21, 0.145, 133, 117, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
428, d3w9tD1, 0.7629, 2.31, 0.171, 140, 117, PORE-FORMING CEL-III
429, p5ajoA2, 0.7628, 1.94, 0.217, 127, 115, CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-313
430, d1wd4A2, 0.7628, 2.22, 0.145, 133, 117, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOSE
431, p4l4iA2, 0.7626, 2.22, 0.145, 133, 117, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547 DISEASE MUTANT R420Q
432, p2vlcB3, 0.7626, 1.86, 0.158, 122, 114, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
433, d3w9tA1, 0.7625, 2.37, 0.144, 137, 118, PORE-FORMING CEL-III
434, d2z49B1, 0.7624, 2.22, 0.145, 133, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
435, p5foyA2, 0.7623, 1.92, 0.191, 127, 115, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
436, d3w9tE1, 0.7623, 1.87, 0.158, 122, 114, PORE-FORMING CEL-III
437, d2d44A2, 0.7623, 2.36, 0.171, 140, 117, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOFURANOSYL-ALPHA-12-XYLOBIOSE
438, d1wd3A2, 0.7623, 2.44, 0.074, 156, 122, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE
439, d2aaiB2, 0.7622, 2.33, 0.133, 135, 120, CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS
440, d2z48B1, 0.7621, 2.36, 0.171, 140, 117, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
441, p6egsB2, 0.7619, 2.36, 0.171, 140, 117, CRYSTAL STRUCTURE OF THE GALNAC-T2 F104S MUTANT IN COMPLEX WITH UDP- GALNAC 
442, d3w9tC1, 0.7619, 2.55, 0.083, 142, 121, PORE-FORMING CEL-III
443, d2z48A1, 0.7619, 1.93, 0.191, 127, 115, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
444, d1jlxB2, 0.7615, 2.35, 0.133, 136, 120, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
445, d2d43A2, 0.7614, 1.92, 0.191, 127, 115, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOTRIOSE
446, d1jlyB2, 0.7612, 2.24, 0.145, 133, 117, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
447, p3a07B_, 0.7611, 2.80, 0.163, 150, 123, CRYSTAL STRUCTURE OF ACTINOHIVIN; POTENT ANTI-HIV PROTEIN
448, p2y9xH_, 0.7611, 2.43, 0.074, 156, 122, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
449, d5muaA1, 0.7609, 2.23, 0.145, 133, 117, PSL1A-E64 COMPLEX
450, d3malB_, 0.7608, 2.80, 0.163, 150, 123, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
451, p5fv9B2, 0.7604, 2.80, 0.163, 150, 123, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
452, d3w9tG1, 0.7604, 2.30, 0.176, 149, 119, PORE-FORMING CEL-III
453, d3malA_, 0.7604, 2.31, 0.176, 149, 119, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
454, p5ndfD2, 0.7603, 2.31, 0.176, 149, 119, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
455, p5xtwC1, 0.7602, 1.97, 0.103, 132, 116, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
456, p5fv9F2, 0.7602, 2.42, 0.183, 149, 120, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
457, p4d0tB2, 0.7602, 1.88, 0.149, 122, 114, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
458, d3w9tB1, 0.7602, 1.88, 0.149, 122, 114, PORE-FORMING CEL-III
459, p5fv9E2, 0.7601, 2.31, 0.176, 149, 119, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
460, p4d0tA2, 0.7600, 1.92, 0.191, 125, 115, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
461, p4usoC_, 0.7599, 2.98, 0.087, 167, 126, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
462, p3a07A_, 0.7599, 2.98, 0.087, 167, 126, CRYSTAL STRUCTURE OF ACTINOHIVIN; POTENT ANTI-HIV PROTEIN
463, p2y9xG_, 0.7599, 2.34, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
464, p4d0zA2, 0.7596, 2.54, 0.083, 141, 121, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
465, p4g1rC_, 0.7595, 2.36, 0.133, 136, 120, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHS-12- MANNOBIOSE (FORM II)
466, p4a7zA3, 0.7594, 2.46, 0.175, 149, 120, COMPLEX OF BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE WITH THE REACTION INTERMEDIATE ASCOPYRONE M
467, p5ndfB2, 0.7593, 1.97, 0.103, 132, 116, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
468, p4d11D2, 0.7591, 2.18, 0.085, 162, 118, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
469, d1jlxA2, 0.7589, 2.59, 0.065, 171, 124, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
470, p4d0tD2, 0.7588, 1.92, 0.191, 125, 115, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
471, p5xtwH1, 0.7585, 2.47, 0.183, 149, 120, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
472, p4p6aA_, 0.7585, 2.31, 0.176, 149, 119, CRYSTAL STRUCTURE OF A POTENT ANTI-HIV LECTIN ACTINOHIVIN IN COMPLEX WITH ALPHA-12-MANNOTRIOSE
473, p4d0tE2, 0.7585, 2.55, 0.083, 144, 121, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
474, d4ekxD_, 0.7584, 2.55, 0.083, 144, 121, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
475, p6egsA2, 0.7583, 2.45, 0.183, 149, 120, CRYSTAL STRUCTURE OF THE GALNAC-T2 F104S MUTANT IN COMPLEX WITH UDP- GALNAC 
476, p5ajnA2, 0.7583, 2.19, 0.085, 162, 118, CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-CYS13
477, d1jlyA2, 0.7583, 2.18, 0.085, 162, 118, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
478, p4d11B2, 0.7582, 2.18, 0.085, 162, 118, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
479, p4g1rA_, 0.7581, 2.09, 0.224, 127, 116, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHS-12- MANNOBIOSE (FORM II)
480, p4d11E2, 0.7580, 2.31, 0.176, 149, 119, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
481, p5xtwF1, 0.7579, 2.00, 0.112, 132, 116, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
482, d1t9fA1, 0.7579, 2.47, 0.183, 149, 120, STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION
483, p4a7yA3, 0.7578, 2.32, 0.176, 149, 119, ACTIVE SITE METAL DEPLETED ALDOS-2-ULOSE DEHYDRATASE
484, p4a7kA3, 0.7578, 2.76, 0.122, 146, 123, BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE
485, p5fv9A2, 0.7575, 2.19, 0.085, 162, 118, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
486, p4d0zD2, 0.7575, 2.77, 0.122, 146, 123, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
487, p4d11A2, 0.7574, 1.97, 0.186, 118, 113, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
488, p4d0zE2, 0.7569, 1.97, 0.186, 118, 113, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
489, p5xtwE1, 0.7566, 2.37, 0.133, 136, 120, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
490, p5ndfA2, 0.7563, 2.02, 0.149, 131, 114, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
491, p5xtwG1, 0.7561, 2.48, 0.066, 181, 121, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
492, p5fv9C2, 0.7560, 2.00, 0.103, 132, 116, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
493, p4jkqA2, 0.7559, 2.47, 0.183, 149, 120, CRYSTAL STRUCTURE OF THE N-TERMINAL REGION OF THE HUMAN RYANODINE RECEPTOR 2
494, p4endA_, 0.7559, 2.46, 0.066, 181, 121, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHA-12- MANNOBIOSE (P 2 21 21 FORM)
495, p3kmvE_, 0.7556, 2.46, 0.066, 181, 121, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
496, d1jlyB1, 0.7556, 2.00, 0.103, 132, 116, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
497, p4d0zB2, 0.7554, 2.35, 0.161, 132, 118, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
498, d1xhbA1, 0.7553, 2.04, 0.112, 130, 116, THE CRYSTAL STRUCTURE OF UDP-GALNAC: POLYPEPTIDE ALPHA-N- ACETYLGALACTOSAMINYLTRANSFERASE-T1
499, d1fwvA_, 0.7553, 2.11, 0.111, 132, 117, CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(A)
500, d3rtiB2, 0.7552, 2.49, 0.175, 149, 120, CRYSTAL STRUCTURE OF RICIN BOUND WITH FORMYCIN MONOPHOSPHATE
501, d1jlxB1, 0.7552, 2.22, 0.111, 130, 117, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
502, p5xtsA1, 0.7550, 2.00, 0.103, 133, 116, CRYSTAL STRUCTURE OF THE CYSR-CTLD3 FRAGMENT OF HUMAN MR AT BASIC/NEUTRAL PH
503, d1fwuA_, 0.7550, 2.00, 0.103, 133, 116, CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(X)
504, p4d0zF2, 0.7549, 2.15, 0.113, 130, 115, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
505, d1dqoA_, 0.7548, 1.97, 0.186, 116, 113, CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH ACETYLGALACTOSAMINE-4-SULFATE
506, p5ndfF2, 0.7544, 2.37, 0.133, 136, 120, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
507, d1n4kA2, 0.7542, 2.01, 0.103, 132, 116, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR BINDING CORE IN COMPLEX WITH IP3
508, d1dqgA_, 0.7542, 1.82, 0.187, 114, 112, CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR
509, p4d0zC2, 0.7541, 2.77, 0.107, 150, 121, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
510, p4d0tC2, 0.7541, 2.12, 0.111, 132, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
511, p5ndfC2, 0.7537, 2.22, 0.103, 132, 117, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
512, p5xtwB1, 0.7536, 2.79, 0.122, 146, 123, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
513, p5xtwA1, 0.7534, 2.79, 0.122, 146, 123, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
514, d1jlyA1, 0.7534, 2.12, 0.111, 132, 117, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
515, p5xtwD1, 0.7533, 2.37, 0.161, 132, 118, CRYSTAL STRUCTURE OF THE CYSR-CTLD2 FRAGMENT OF HUMAN MR AT ACIDIC PH
516, d1jlxA1, 0.7531, 1.82, 0.187, 114, 112, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
517, d4xfsA_, 0.7527, 2.02, 0.103, 132, 116, STRUCTURE OF IL-18 SER MUTANT I
518, p4usoD_, 0.7525, 2.55, 0.139, 155, 122, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
519, p3kmvH_, 0.7521, 2.06, 0.121, 131, 116, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
520, d3wo3K_, 0.7514, 2.04, 0.112, 130, 116, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
521, d4xftB_, 0.7509, 2.79, 0.122, 146, 123, STRUCTURE OF IL-18 SER MUTANT III
522, p3kmvG_, 0.7508, 2.23, 0.103, 133, 117, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
523, d4xfsB_, 0.7507, 1.83, 0.187, 114, 112, STRUCTURE OF IL-18 SER MUTANT I
524, p3kmvB_, 0.7502, 2.23, 0.103, 132, 117, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
525, p3kmvD_, 0.7500, 2.37, 0.161, 132, 118, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
526, p3q7wA_, 0.7496, 2.57, 0.066, 176, 122, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
527, p4l4hA2, 0.7485, 2.57, 0.066, 176, 122, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547
528, p1w3gA1, 0.7485, 2.83, 0.107, 150, 121, HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH TWO N-ACETYLLACTOSAMINE MOLECULES.
529, d3wo3I_, 0.7481, 2.80, 0.107, 150, 121, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
530, p5ndfE2, 0.7477, 2.80, 0.107, 150, 121, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
531, d3wo3C_, 0.7476, 2.03, 0.103, 132, 116, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
532, p1w3fA1, 0.7476, 2.27, 0.111, 130, 117, CRYSTAL STRUCTURE OF THE HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH N-ACETYLLACTOSAMINE IN THE GAMMA MOTIF
533, p6dqjD3, 0.7475, 2.03, 0.103, 132, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
534, p6dqjC3, 0.7475, 2.07, 0.112, 130, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
535, p6dqjB3, 0.7475, 2.37, 0.153, 132, 118, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
536, p6dqjA3, 0.7475, 2.07, 0.112, 130, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
537, d1xzzA1, 0.7473, 2.38, 0.161, 132, 118, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 1 INOSITOL 145-TRISPHOSPHATE RECEPTOR
538, d3wo3E_, 0.7472, 2.36, 0.119, 130, 118, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
539, p1w3aA1, 0.7470, 2.62, 0.066, 179, 122, THREE DIMENSIONAL STRUCTURE OF A NOVEL PORE-FORMING LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS
540, d3wo3G_, 0.7469, 1.86, 0.187, 114, 112, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
541, d3wo3A_, 0.7469, 2.24, 0.095, 140, 116, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
542, p3kmvF_, 0.7468, 2.24, 0.095, 140, 116, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
543, p6dqnD3, 0.7466, 2.65, 0.114, 153, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
544, p6dqnC3, 0.7466, 2.19, 0.120, 130, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
545, p6dqnB3, 0.7466, 2.44, 0.132, 131, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
546, p6dqnA3, 0.7466, 2.44, 0.132, 131, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
547, p3uj0A1, 0.7466, 2.36, 0.119, 134, 118, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
548, p3uj0B1, 0.7463, 1.87, 0.214, 124, 112, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
549, p6dqzC3, 0.7462, 2.67, 0.138, 153, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
550, d4xftA_, 0.7461, 2.38, 0.161, 133, 118, STRUCTURE OF IL-18 SER MUTANT III
551, d5y9vB_, 0.7460, 2.36, 0.119, 134, 118, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
552, p6dqzD3, 0.7458, 2.09, 0.112, 130, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
553, d2vxtI_, 0.7457, 2.36, 0.119, 134, 118, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
554, p6dr0D3, 0.7456, 2.19, 0.120, 130, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
555, p4f34C_, 0.7456, 2.48, 0.091, 142, 121, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
556, p4qksA_, 0.7455, 2.37, 0.119, 134, 118, CRYSTAL STRUCTURE OF 6XTRP/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22W/L44W/L64W/L85W/L108W/L132W HIS PRIMITIVE VERSION 2)
557, p2liqA_, 0.7451, 2.37, 0.119, 134, 118, SOLUTION STRUCTURE OF CCL2 IN COMPLEX WITH GLYCAN
558, p3uj4B1, 0.7450, 2.09, 0.112, 129, 116, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
559, p5gugA3, 0.7449, 2.19, 0.120, 130, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
560, p3uj0A3, 0.7449, 2.20, 0.120, 130, 117, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
561, p3uj0B3, 0.7448, 2.33, 0.162, 131, 117, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
562, p4qkrA_, 0.7447, 2.34, 0.162, 131, 117, CRYSTAL STRUCTURE OF 6XTYR/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22Y/L44Y/L64Y/L85Y/L108Y/L132Y PRIMITIVE VERSION 2)
563, p3kmvC_, 0.7447, 2.67, 0.138, 153, 123, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
564, p6dr0B3, 0.7446, 2.34, 0.162, 131, 117, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
565, p5gugA1, 0.7446, 2.68, 0.138, 153, 123, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
566, p6dqzA3, 0.7445, 2.68, 0.138, 153, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
567, p6dqvD3, 0.7444, 2.56, 0.139, 156, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
568, p6dqvC3, 0.7444, 2.03, 0.115, 130, 113, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
569, p6dqvB3, 0.7444, 2.18, 0.087, 139, 115, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
570, p6dqvA3, 0.7444, 2.57, 0.148, 156, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
571, p6dqzD1, 0.7443, 2.59, 0.139, 154, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
572, p6dqzB3, 0.7443, 2.18, 0.087, 138, 115, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
573, p4qd2G_, 0.7443, 2.56, 0.131, 157, 122, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
574, p6dr0A3, 0.7440, 2.18, 0.087, 138, 115, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
575, p3uj4A1, 0.7440, 2.24, 0.078, 138, 115, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
576, p4lo3C_, 0.7439, 2.02, 0.132, 124, 114, HA17-HA33-LACNAC
577, p6dr2D3, 0.7438, 2.55, 0.066, 165, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
578, p6dr2C3, 0.7438, 2.83, 0.131, 147, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
579, p6dr2B3, 0.7438, 2.60, 0.148, 156, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
580, p6dr2A3, 0.7438, 2.23, 0.112, 126, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
581, p6dqzC1, 0.7438, 2.63, 0.148, 156, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
582, d3im5B_, 0.7433, 2.82, 0.131, 147, 122, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
583, p6drcD3, 0.7431, 2.82, 0.098, 184, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
584, p6drcC3, 0.7431, 2.82, 0.098, 184, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
585, p6drcA3, 0.7431, 2.82, 0.098, 184, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
586, p4lo2C_, 0.7431, 2.82, 0.098, 184, 123, HA17-HA33-LAC
587, p6drcB3, 0.7430, 2.45, 0.042, 211, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
588, p2y9fA_, 0.7430, 2.61, 0.148, 157, 122, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR- RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B- TREFOIL LECTIN DOMAIN
589, d4hjjA1, 0.7429, 2.82, 0.131, 147, 122, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
590, d3wo4A_, 0.7429, 2.60, 0.148, 156, 122, CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX
591, p5xa1A1, 0.7428, 2.61, 0.148, 156, 122, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
592, p5bp5C_, 0.7428, 2.14, 0.079, 137, 114, CRYSTAL STRUCTURE OF HA17-HA33-IPT
593, p4lo1C_, 0.7428, 2.76, 0.090, 188, 122, HA17-HA33-GAL
594, p3q7xA_, 0.7427, 2.76, 0.090, 188, 122, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
595, d3jrrA_, 0.7427, 2.76, 0.090, 188, 122, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
596, p4qd2B_, 0.7426, 2.76, 0.090, 188, 122, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
597, p4denA_, 0.7426, 2.48, 0.042, 178, 119, STRUCTURAL INSIGHTSINTO POTENT SPECIFIC ANTI-HIV PROPERTY OF ACTINOHIVIN; CRYSTAL STRUCTURE OF ACTINOHIVIN IN COMPLEX WITH ALPHA(1-2) MANNOBIOSE MOIETY OF HIGH-MANNOSE TYPE GLYCAN OF GP120
598, d3jrrB_, 0.7426, 2.48, 0.042, 178, 119, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
599, p5xa1B1, 0.7425, 2.77, 0.090, 192, 122, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
600, p5bquC_, 0.7425, 2.58, 0.132, 154, 121, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
601, p3t8sA3, 0.7425, 2.28, 0.085, 170, 117, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
602, p4d8hA_, 0.7424, 2.77, 0.090, 192, 122, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 2 (6XLEU / PV1)
603, p4lo7G_, 0.7423, 2.69, 0.148, 156, 122, HA70(D3)-HA17-HA33
604, p4lo7C_, 0.7423, 2.61, 0.091, 188, 121, HA70(D3)-HA17-HA33
605, p4lo0C_, 0.7423, 2.05, 0.114, 124, 114, APO HA17-HA33
606, p6dqsD1, 0.7421, 2.05, 0.123, 124, 114, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
607, p6dqsC3, 0.7421, 2.32, 0.112, 140, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
608, p6dqsA3, 0.7421, 2.32, 0.112, 140, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
609, p4lo8H_, 0.7421, 2.45, 0.042, 179, 119, HA70(D3)-HA17
610, p3t8sA1, 0.7421, 2.60, 0.091, 170, 121, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
611, d4r6uB_, 0.7420, 2.62, 0.091, 167, 121, IL-18 RECEPTOR COMPLEX
612, p6dr0C3, 0.7419, 2.62, 0.091, 167, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
613, p6dqjD1, 0.7419, 2.07, 0.114, 124, 114, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
614, p6dqjC1, 0.7419, 2.18, 0.079, 137, 114, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
615, p6dqjB1, 0.7419, 2.62, 0.091, 188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
616, p6dqjA1, 0.7419, 2.51, 0.042, 179, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
617, d4r6uD_, 0.7419, 2.63, 0.091, 188, 121, IL-18 RECEPTOR COMPLEX
618, d3wo2D_, 0.7416, 2.63, 0.091, 188, 121, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
619, p4lo8B_, 0.7415, 2.63, 0.091, 188, 121, HA70(D3)-HA17
620, p3t8sB1, 0.7415, 2.63, 0.091, 188, 121, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
621, p3uj4B3, 0.7414, 2.63, 0.091, 188, 121, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
622, p4lo8F_, 0.7413, 2.41, 0.034, 181, 119, HA70(D3)-HA17
623, p3kmvA_, 0.7411, 2.63, 0.091, 188, 121, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
624, p6draD3, 0.7410, 2.50, 0.155, 143, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
625, p6draC3, 0.7410, 2.64, 0.091, 188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
626, p6draB3, 0.7410, 2.47, 0.042, 174, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
627, p6draA3, 0.7410, 2.52, 0.172, 144, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
628, p6dqsB1, 0.7410, 2.71, 0.090, 193, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
629, d3wo2B_, 0.7410, 2.71, 0.090, 193, 122, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
630, p6dqsB3, 0.7403, 2.71, 0.090, 193, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
631, p5gugB1, 0.7402, 2.71, 0.090, 193, 122, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
632, p6dqsC1, 0.7400, 2.41, 0.034, 181, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
633, d3wo2A_, 0.7400, 2.37, 0.085, 175, 118, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
634, p3q7yA_, 0.7398, 2.76, 0.090, 184, 122, CRYSTAL STRUCTURE OF K15R/E18D/Y22W/H41G/F44W/E51D/E53P/K57R/E60D/Y64W/H82G/F85W/E90D/E94P /K98R/E101D/Y108W/H129G/F132W/E137D SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
635, p3o4dA_, 0.7397, 2.76, 0.090, 184, 122, CRYSTAL STRUCTURE OF SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
636, p6dqnD1, 0.7396, 2.76, 0.090, 184, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
637, p6dqnC1, 0.7396, 2.52, 0.164, 144, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
638, p6dqnB1, 0.7396, 2.76, 0.090, 184, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
639, p6dqnA1, 0.7396, 2.65, 0.132, 149, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
640, d4kejA_, 0.7396, 2.65, 0.132, 149, 121, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R169Q
641, d3im7A_, 0.7395, 2.72, 0.156, 156, 122, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 N-TERMINAL DOMAIN (1-217) DISEASE MUTANT A77V
642, p6dr0C1, 0.7394, 2.62, 0.148, 157, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
643, p6dqsA1, 0.7393, 2.48, 0.042, 178, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
644, p4f34A_, 0.7392, 2.52, 0.164, 144, 116, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
645, p2lieA_, 0.7387, 2.52, 0.164, 144, 116, NMR STRUCTURE OF THE LECTIN CCL2
646, p4lo8D_, 0.7386, 2.04, 0.115, 124, 113, HA70(D3)-HA17
647, d3wo2C_, 0.7386, 2.44, 0.042, 216, 119, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
648, p5gugB3, 0.7385, 2.51, 0.155, 143, 116, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
649, p3o4cA_, 0.7385, 1.84, 0.191, 112, 110, CRYSTAL STRUCTURE OF SYMFOIL-4V: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
650, p3vwcA_, 0.7382, 2.44, 0.042, 219, 119, HIGH RESOLUTION STRUCTURE OF PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
651, p3o4bA_, 0.7382, 2.44, 0.042, 219, 119, CRYSTAL STRUCTURE OF SYMFOIL-4T: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
652, p6dqsD3, 0.7381, 2.51, 0.042, 178, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
653, p3t8sB3, 0.7381, 2.52, 0.164, 144, 116, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
654, p3n0kA_, 0.7381, 2.70, 0.091, 177, 121, PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
655, p3winC_, 0.7380, 2.08, 0.105, 124, 114, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
656, p1xezA3, 0.7380, 2.52, 0.164, 139, 116, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) PRO-TOXIN WITH OCTYLGLUCOSIDE BOUND
657, d4keiA_, 0.7378, 2.52, 0.164, 139, 116, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT P164S
658, p4f34B_, 0.7376, 2.52, 0.164, 144, 116, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
659, p4l4iA1, 0.7375, 2.52, 0.164, 144, 116, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547 DISEASE MUTANT R420Q
660, p2e4mC_, 0.7375, 2.42, 0.034, 181, 119, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
661, d2mc2A_, 0.7374, 2.78, 0.090, 189, 122, X-RAY CRYSTALLOGRAPHY-SOLUTION NMR HYBRID STRUCTURE OF MOUSE RYR2 DOMAIN A
662, p4l4hA1, 0.7367, 2.77, 0.090, 188, 122, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547
663, p2y9gA_, 0.7367, 2.51, 0.164, 143, 116, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR-RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B-TREFOIL LECTIN DOMAIN
664, d3im5A_, 0.7366, 2.48, 0.042, 179, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
665, p3o4aB_, 0.7365, 2.59, 0.140, 155, 121, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
666, p5g56A4, 0.7363, 2.80, 0.090, 192, 122, THE TETRA-MODULAR CELLULOSOMAL ARABINOXYLANASE CTXYL5A STRUCTURE AS REVEALED BY X-RAY CRYSTALLOGRAPHY
667, p3o4aA_, 0.7363, 2.43, 0.042, 181, 119, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
668, p5xa1A3, 0.7362, 2.43, 0.042, 181, 119, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
669, p3uj4A3, 0.7362, 2.43, 0.042, 181, 119, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
670, d3im6A_, 0.7361, 2.43, 0.042, 181, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 MUTANT V186M
671, p3o49A_, 0.7359, 2.59, 0.140, 155, 121, CRYSTAL STRUCTURE OF SYMFOIL-1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
672, p3o4aC_, 0.7358, 2.70, 0.148, 157, 122, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
673, p3o4aD_, 0.7355, 2.52, 0.164, 143, 116, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
674, p2ffvB2, 0.7353, 2.68, 0.042, 174, 120, HUMAN PPGALNACT-2 COMPLEXED WITH MANGANESE AND UDP
675, p6draD1, 0.7348, 2.91, 0.089, 182, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
676, p6draC1, 0.7348, 2.54, 0.164, 142, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
677, p6draB1, 0.7348, 2.14, 0.080, 136, 113, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
678, p6draA1, 0.7348, 2.73, 0.090, 189, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
679, p5xa1B3, 0.7346, 2.73, 0.090, 189, 122, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
680, p6dr0B1, 0.7344, 2.73, 0.090, 189, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
681, p4f34D_, 0.7344, 2.73, 0.090, 189, 122, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
682, p6dqzA1, 0.7340, 2.43, 0.042, 181, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
683, p6drcD1, 0.7339, 2.70, 0.148, 156, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
684, p6drcC1, 0.7339, 2.80, 0.090, 188, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
685, p6drcB1, 0.7339, 2.66, 0.042, 178, 120, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
686, p6drcA1, 0.7339, 2.45, 0.034, 180, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
687, p6dr0D1, 0.7339, 2.72, 0.148, 157, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
688, p6dr2D1, 0.7336, 2.07, 0.115, 124, 113, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
689, p6dr2C1, 0.7336, 2.03, 0.133, 123, 113, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
690, p6dr2B1, 0.7336, 2.51, 0.042, 175, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
691, p6dr2A1, 0.7336, 2.51, 0.042, 175, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
692, p2ffvA2, 0.7335, 2.51, 0.042, 175, 119, HUMAN PPGALNACT-2 COMPLEXED WITH MANGANESE AND UDP
693, p6dr0A1, 0.7333, 2.51, 0.042, 175, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
694, p6dqzB1, 0.7331, 2.63, 0.092, 172, 119, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
695, d3ilaD_, 0.7329, 2.61, 0.092, 174, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
696, p3akhA3, 0.7322, 2.44, 0.034, 181, 119, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-15-L-ARABINOFURANOTRIOSE
697, p4jkqA1, 0.7317, 2.43, 0.034, 181, 119, CRYSTAL STRUCTURE OF THE N-TERMINAL REGION OF THE HUMAN RYANODINE RECEPTOR 2
698, p6dqvD1, 0.7315, 2.03, 0.124, 123, 113, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
699, p6dqvC1, 0.7315, 2.41, 0.112, 139, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
700, p6dqvB1, 0.7315, 2.54, 0.164, 143, 116, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
701, p6dqvA1, 0.7315, 2.72, 0.148, 157, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
702, d2m49A_, 0.7314, 2.65, 0.091, 165, 121, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
703, d5y9vA_, 0.7313, 2.04, 0.124, 124, 113, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
704, d2hz9A1, 0.7313, 3.00, 0.107, 146, 121, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
705, p3akfA3, 0.7311, 2.04, 0.115, 123, 113, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE
706, d2vuaA2, 0.7307, 2.84, 0.090, 191, 122, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN
707, d2m49C_, 0.7304, 2.77, 0.082, 160, 122, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
708, d5jlvB2, 0.7303, 2.99, 0.107, 150, 121, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
709, p4i0yA2, 0.7303, 2.99, 0.107, 150, 121, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT C36R
710, d2vu9A2, 0.7302, 2.49, 0.165, 141, 115, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B
711, p3o44N2, 0.7300, 2.15, 0.123, 124, 114, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
712, p3o44G2, 0.7300, 2.62, 0.092, 173, 119, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
713, p3o44E2, 0.7299, 2.06, 0.124, 123, 113, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
714, p3o44B2, 0.7299, 2.63, 0.092, 172, 119, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
715, p3o44A2, 0.7299, 2.49, 0.155, 143, 116, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
716, p3o44I2, 0.7298, 2.45, 0.085, 206, 118, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
717, p3o44D2, 0.7298, 2.45, 0.085, 206, 118, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
718, p4i3nA2, 0.7297, 2.63, 0.092, 172, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT D61N
719, p3o44L2, 0.7297, 2.83, 0.132, 147, 121, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
720, p3o44M2, 0.7296, 2.45, 0.085, 173, 118, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
721, p3o44K2, 0.7296, 2.05, 0.115, 123, 113, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
722, p3o44H2, 0.7296, 2.48, 0.231, 132, 117, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
723, p3o44F2, 0.7296, 2.48, 0.231, 132, 117, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
724, p3o44C2, 0.7296, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
725, p3o44J2, 0.7295, 2.72, 0.083, 171, 121, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
726, d3k1xA_, 0.7294, 2.86, 0.099, 178, 121, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
727, d3fjdB1, 0.7292, 2.63, 0.092, 173, 119, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
728, d2ntdB_, 0.7292, 2.06, 0.115, 123, 113, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
729, d4q9gA1, 0.7290, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
730, d2ntdD_, 0.7290, 2.06, 0.115, 123, 113, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
731, d2hz9B1, 0.7290, 2.16, 0.114, 131, 114, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
732, d3jutA_, 0.7289, 2.49, 0.034, 179, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
733, d1hknC_, 0.7289, 2.49, 0.034, 179, 119, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
734, d3r4uB2, 0.7288, 2.49, 0.034, 179, 119, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
735, d3r4uA2, 0.7288, 2.49, 0.034, 179, 119, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
736, d2hwmA1, 0.7288, 2.72, 0.083, 171, 121, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
737, d3halA_, 0.7287, 2.53, 0.042, 180, 119, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
738, d1hknE_, 0.7287, 2.02, 0.125, 122, 112, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
739, d4xfuA_, 0.7286, 2.48, 0.042, 180, 119, STRUCTURE OF IL-18 SER MUTANT V
740, d3k1xF_, 0.7286, 2.56, 0.042, 175, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
741, p3akgA3, 0.7285, 2.56, 0.042, 175, 119, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-15-L-ARABINOFURANOBIOSE
742, d2ntdC_, 0.7285, 2.56, 0.042, 175, 119, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
743, d2d20A2, 0.7285, 2.56, 0.042, 175, 119, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
744, d2afgA_, 0.7285, 2.54, 0.042, 180, 119, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
745, d4q91A1, 0.7284, 2.51, 0.034, 175, 119, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
746, d3jutC_, 0.7284, 2.51, 0.034, 175, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
747, d3jutB_, 0.7284, 2.51, 0.034, 175, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
748, d3fjkA1, 0.7284, 2.51, 0.034, 175, 119, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
749, d2fdbN_, 0.7284, 2.18, 0.123, 129, 114, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
750, d2fdbM1, 0.7284, 2.55, 0.050, 180, 119, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
751, p5mk6A2, 0.7283, 2.49, 0.042, 180, 119, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 1)
752, d3n7kA2, 0.7282, 2.19, 0.079, 162, 114, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
753, d2d24B2, 0.7282, 2.23, 0.044, 135, 113, CRYSTAL STRUCTURE OF ES COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
754, d3ud8A_, 0.7280, 2.77, 0.084, 184, 119, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
755, p3akiA3, 0.7280, 2.51, 0.042, 180, 119, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-L-ARABINOFURANOSYL AZIDO
756, d2d22A2, 0.7280, 2.51, 0.042, 180, 119, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
757, d3ojvB_, 0.7279, 2.51, 0.042, 180, 119, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
758, d3k1xB_, 0.7279, 2.51, 0.042, 180, 119, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
759, d3ojvA_, 0.7278, 2.22, 0.096, 126, 115, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
760, d3fjkD1, 0.7278, 2.56, 0.093, 177, 118, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
761, d3fjjB1, 0.7278, 2.35, 0.103, 137, 116, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
762, d3fgmA1, 0.7277, 2.23, 0.044, 135, 113, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
763, d1jtcB1, 0.7277, 2.73, 0.082, 216, 122, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
764, d3jutE_, 0.7276, 2.23, 0.096, 126, 115, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
765, d3fjeB1, 0.7275, 2.71, 0.082, 202, 122, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
766, d3fj9B1, 0.7274, 2.73, 0.059, 168, 119, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
767, d1nzkB_, 0.7274, 2.72, 0.082, 218, 122, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
768, d1jt7B1, 0.7274, 2.72, 0.082, 218, 122, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
769, p4i2sA2, 0.7273, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT I404M
770, d3fjcA1, 0.7273, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
771, d3fj9A1, 0.7273, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
772, d3fgmB1, 0.7273, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
773, d2j3pB_, 0.7273, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
774, d1jtcD1, 0.7273, 2.19, 0.124, 127, 113, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
775, d3fjaA1, 0.7272, 2.20, 0.124, 127, 113, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
776, d3fjdA1, 0.7271, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
777, d1jqzB1, 0.7271, 2.68, 0.059, 181, 118, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
778, d3homB1, 0.7270, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
779, d2ntdA_, 0.7270, 2.20, 0.124, 127, 113, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
780, d2hw9A1, 0.7270, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
781, d1evtB_, 0.7270, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
782, d1evtA_, 0.7270, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
783, d4fvvA2, 0.7269, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
784, d3n7kB2, 0.7269, 2.19, 0.124, 127, 113, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
785, d3fjfA1, 0.7269, 2.41, 0.103, 130, 116, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
786, d2d20B2, 0.7269, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
787, d4qbcB1, 0.7268, 2.39, 0.103, 143, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
788, d3criB1, 0.7268, 2.37, 0.121, 137, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
789, d1jt7D1, 0.7268, 2.39, 0.103, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
790, p4i6iA2, 0.7267, 2.38, 0.095, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-559) DISEASE MUTANT R45C
791, d3k1xE_, 0.7267, 2.35, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
792, d3halB_, 0.7267, 2.39, 0.112, 129, 116, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
793, d3fjkB1, 0.7267, 2.61, 0.058, 198, 120, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
794, d1jt4A1, 0.7267, 2.61, 0.058, 198, 120, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
795, d3bahA1, 0.7266, 2.39, 0.112, 137, 116, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
796, d2fgfA_, 0.7266, 2.36, 0.095, 131, 116, THREE-DIMENSIONAL STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR A STRUCTURAL HOMOLOG OF INTERLEUKIN 1BETA
797, d2d24A2, 0.7266, 2.34, 0.112, 130, 116, CRYSTAL STRUCTURE OF ES COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
798, d2d22B2, 0.7266, 2.68, 0.143, 149, 119, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
799, d4qbcA1, 0.7265, 2.33, 0.112, 130, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
800, d4kekA_, 0.7265, 2.28, 0.044, 135, 113, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R176Q
801, d4qbvA1, 0.7264, 2.39, 0.121, 142, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
802, p4ow4A_, 0.7264, 2.05, 0.185, 115, 108, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
803, d3baqA1, 0.7264, 2.30, 0.113, 129, 115, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
804, d1jtcC1, 0.7264, 2.39, 0.112, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
805, d3bauB1, 0.7263, 2.38, 0.103, 130, 116, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
806, d1jy0A1, 0.7263, 2.39, 0.112, 130, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
807, d3fjaB1, 0.7262, 2.39, 0.103, 137, 116, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
808, d2hwaA1, 0.7262, 2.43, 0.060, 148, 117, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
809, d2d1zB2, 0.7262, 2.43, 0.060, 148, 117, CRYSTAL STRUCTURE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
810, d2afgB_, 0.7262, 2.43, 0.060, 147, 117, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
811, d1jqzA1, 0.7262, 2.74, 0.090, 202, 122, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
812, d1hknD_, 0.7262, 2.62, 0.058, 197, 120, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
813, d1bfgA_, 0.7262, 2.25, 0.183, 115, 109, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
814, d3ojmA_, 0.7261, 2.38, 0.103, 129, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING P253R APERT MUTATION
815, d3criA1, 0.7261, 2.27, 0.044, 135, 113, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
816, d3crhB1, 0.7261, 2.24, 0.183, 115, 109, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
817, d3baoA1, 0.7261, 2.36, 0.112, 133, 116, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
818, d3badA_, 0.7261, 2.41, 0.112, 130, 116, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
819, d2d1zA2, 0.7261, 2.36, 0.112, 133, 116, CRYSTAL STRUCTURE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
820, d1q04B_, 0.7261, 2.34, 0.104, 137, 115, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
821, d1q04A_, 0.7261, 2.39, 0.112, 137, 116, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
822, d1jt4B1, 0.7261, 2.41, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
823, p4i3nA1, 0.7260, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT D61N
824, d3bauA1, 0.7260, 2.34, 0.112, 130, 116, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
825, d1p63B_, 0.7260, 2.40, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
826, d4qc4A1, 0.7259, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
827, d3ba7B1, 0.7259, 2.39, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
828, d2hwmB1, 0.7259, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
829, d1nzkD_, 0.7259, 2.62, 0.060, 166, 117, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
830, d1jtcA1, 0.7259, 2.40, 0.121, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
831, d3r4sA2, 0.7258, 2.40, 0.121, 137, 116, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
832, d3cqaB_, 0.7258, 2.42, 0.103, 137, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
833, d2d23A2, 0.7258, 2.38, 0.103, 132, 116, CRYSTAL STRUCTURE OF EP COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
834, d1rg8A1, 0.7258, 2.41, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
835, d5jlvA2, 0.7257, 2.40, 0.103, 137, 116, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
836, d3fjfB1, 0.7257, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
837, d3fjcB1, 0.7257, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
838, d3ba5A1, 0.7257, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
839, d3b9uA_, 0.7257, 2.40, 0.121, 142, 116, CRYSTAL STRUCTURE OF L26N/D28N/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
840, p2xoaA2, 0.7257, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF THE N-TERMINAL THREE DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RYR1)
841, p5g37B1, 0.7256, 2.39, 0.112, 131, 116, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
842, d3bb2B1, 0.7256, 2.40, 0.112, 131, 116, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
843, d3bb2A1, 0.7256, 2.70, 0.066, 207, 122, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
844, d3bavA1, 0.7256, 2.91, 0.057, 197, 122, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
845, d3ba5B1, 0.7256, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
846, d3ba4A1, 0.7256, 2.26, 0.183, 115, 109, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
847, d4q9pB1, 0.7255, 2.39, 0.112, 137, 116, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
848, d3jutD_, 0.7255, 2.39, 0.103, 137, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
849, d3baoB1, 0.7255, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
850, d1m16A_, 0.7255, 2.79, 0.059, 187, 119, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
851, d4q9gB1, 0.7254, 2.79, 0.059, 187, 119, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
852, d3homA1, 0.7254, 2.36, 0.112, 130, 116, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
853, d3crgB1, 0.7254, 2.39, 0.095, 131, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
854, d2ldnA_, 0.7254, 2.39, 0.103, 137, 116,  
855, d3k1xC_, 0.7253, 2.40, 0.121, 137, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
856, d3fjbA1, 0.7253, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
857, d1jy0B1, 0.7253, 2.28, 0.096, 126, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
858, d3r4sB2, 0.7252, 2.27, 0.183, 115, 109, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
859, d3fjiA1, 0.7252, 2.27, 0.183, 115, 109, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
860, d3fj8A1, 0.7252, 2.39, 0.103, 137, 116, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
861, d3crhA1, 0.7252, 2.44, 0.086, 167, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
862, d3bavB1, 0.7252, 2.38, 0.112, 137, 116, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
863, d3bahB1, 0.7252, 2.18, 0.115, 123, 113, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
864, d3ba7A1, 0.7252, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
865, d1k5uA_, 0.7252, 2.40, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
866, p6es1A2, 0.7251, 2.41, 0.121, 137, 116, CRYSTAL STRUCTURE OF THE BINDING DOMAIN FROM BOTULINUM NEUROTOXIN A2 BOUND TO EXTRACELLULAR DOMAIN OF HUMAN RECEPTOR SV2C 
867, d5tpcA2, 0.7251, 2.40, 0.112, 137, 116, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE
868, d3jutF_, 0.7251, 2.40, 0.103, 137, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
869, d3fjkC1, 0.7251, 2.40, 0.112, 137, 116, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
870, d3badB_, 0.7251, 2.28, 0.183, 115, 109, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
871, d1q03B_, 0.7251, 2.33, 0.113, 129, 115, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
872, d5jmcA2, 0.7250, 2.41, 0.112, 137, 116, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
873, d3udaC_, 0.7250, 2.32, 0.113, 129, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
874, d3fjjA1, 0.7250, 2.28, 0.096, 126, 115, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
875, d3fjhB1, 0.7250, 2.40, 0.112, 145, 116, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
876, d3fjeA1, 0.7250, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
877, d3baqB1, 0.7250, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
878, d3ba4B1, 0.7250, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
879, d2d23B2, 0.7250, 2.39, 0.112, 131, 116, CRYSTAL STRUCTURE OF EP COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
880, d1nzkC_, 0.7250, 2.26, 0.183, 115, 109, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
881, d5lr0B2, 0.7249, 2.40, 0.103, 141, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
882, d4qalA1, 0.7249, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
883, d1ry7A_, 0.7249, 2.41, 0.112, 137, 116, CRYSTAL STRUCTURE OF THE 3 IG FORM OF FGFR3C IN COMPLEX WITH FGF1
884, d2hwaB1, 0.7248, 2.70, 0.084, 177, 119, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
885, d1q03A_, 0.7248, 2.41, 0.121, 137, 116, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
886, d1nzkA_, 0.7248, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
887, d1k5uC_, 0.7248, 2.39, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
888, d5lr0A2, 0.7247, 2.42, 0.112, 137, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
889, d1pzzB_, 0.7247, 2.43, 0.103, 137, 116, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
890, d1jt7C1, 0.7247, 2.41, 0.112, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
891, d1cvsB_, 0.7247, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
892, d4yolB1, 0.7246, 2.64, 0.058, 198, 120, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
893, p3v0bA3, 0.7246, 2.42, 0.103, 141, 116, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
894, p3v0aA3, 0.7246, 2.27, 0.183, 115, 109, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
895, d3fjbB1, 0.7246, 2.41, 0.112, 137, 116, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
896, d1rg8B1, 0.7246, 2.76, 0.082, 202, 122, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
897, d1p63A_, 0.7246, 2.40, 0.112, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
898, d4xfuB_, 0.7245, 2.42, 0.121, 137, 116, STRUCTURE OF IL-18 SER MUTANT V
899, d3cqaA_, 0.7245, 2.41, 0.121, 137, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
900, d2bfhA_, 0.7245, 2.39, 0.103, 132, 116, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
901, d1ev2A_, 0.7245, 2.79, 0.059, 172, 118, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
902, d4yolA1, 0.7244, 2.59, 0.121, 171, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
903, d4q91B1, 0.7244, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
904, p4i7iA2, 0.7244, 2.41, 0.112, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT L14R
905, d3fjiC1, 0.7244, 2.41, 0.112, 137, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
906, d1pzzA_, 0.7244, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
907, d1m16B_, 0.7244, 2.41, 0.112, 139, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
908, d1ev2D_, 0.7244, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
909, d1cvsA_, 0.7244, 2.41, 0.103, 130, 116, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
910, d4xkiB1, 0.7243, 2.42, 0.103, 137, 116, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
911, d4qc4B1, 0.7243, 2.41, 0.121, 142, 116, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
912, d4qbvB1, 0.7243, 2.43, 0.112, 137, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
913, d1jt3A1, 0.7243, 2.40, 0.112, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
914, d1ev2C_, 0.7243, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
915, d1ev2B_, 0.7243, 2.42, 0.112, 130, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
916, d3fjhA1, 0.7242, 2.42, 0.103, 130, 116, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
917, d1jt5A1, 0.7242, 2.41, 0.121, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
918, d4q9pA_, 0.7241, 2.43, 0.103, 137, 116, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
919, d4goyB3, 0.7241, 2.65, 0.058, 198, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
920, d3bagA1, 0.7241, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
921, p4ow4B_, 0.7240, 2.42, 0.112, 137, 116, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
922, p4i1eA2, 0.7240, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT G249R
923, d2hw9B1, 0.7240, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
924, d1jt7A1, 0.7240, 2.42, 0.103, 137, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
925, d5tpbB2, 0.7239, 2.42, 0.112, 137, 116, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
926, d1jt3B1, 0.7239, 2.33, 0.104, 129, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
927, d1iilC_, 0.7239, 2.93, 0.081, 204, 123, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
928, d4qalB1, 0.7238, 2.77, 0.082, 217, 122, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
929, p3v0cA4, 0.7238, 2.37, 0.112, 130, 116, 4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)
930, d1ii4A_, 0.7238, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
931, d1hknA_, 0.7238, 2.32, 0.104, 129, 115, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
932, d1fq9B_, 0.7238, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
933, p4i4pB_, 0.7237, 2.77, 0.082, 193, 122, BEL BETA-TREFOIL APO CRYSTAL FORM 2
934, d1fq9A_, 0.7237, 2.31, 0.113, 129, 115, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
935, d1ii4B_, 0.7236, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
936, d5jmcE2, 0.7235, 2.41, 0.112, 137, 116, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
937, p4i2sA1, 0.7235, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT I404M
938, d1iilD_, 0.7235, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
939, d3fj8B1, 0.7234, 2.42, 0.112, 139, 116, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
940, d1iilB_, 0.7234, 2.29, 0.183, 115, 109, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
941, p4i4xD_, 0.7233, 2.41, 0.121, 141, 116, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
942, d4gp0B3, 0.7233, 2.75, 0.066, 208, 122, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
943, d3fuoA2, 0.7233, 2.41, 0.103, 138, 116, THE CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A
944, d3crgA1, 0.7233, 2.40, 0.103, 151, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
945, d1iilA_, 0.7233, 2.42, 0.112, 137, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
946, d3bagB1, 0.7232, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
947, d1ii4D_, 0.7232, 2.42, 0.121, 141, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
948, d1ii4C_, 0.7232, 2.33, 0.104, 129, 115, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
949, d1bffA_, 0.7232, 2.69, 0.066, 208, 121, THE 154 AMINO ACID FORM OF HUMAN BASIC FIBROBLAST GROWTH FACTOR
950, p4i4pA_, 0.7231, 2.42, 0.103, 142, 116, BEL BETA-TREFOIL APO CRYSTAL FORM 2
951, p4i37A2, 0.7230, 2.41, 0.121, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT R402G
952, d4xkiA1, 0.7229, 2.35, 0.095, 129, 116, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
953, d3fjiB1, 0.7229, 2.43, 0.112, 138, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
954, d1jt5B1, 0.7229, 2.78, 0.082, 204, 122, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
955, p4i4rD_, 0.7228, 2.78, 0.082, 204, 122, BEL BETA-TREFOIL APO CRYSTAL FORM 4
956, d1e0oC_, 0.7228, 2.44, 0.112, 137, 116, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
957, p6b0tB3, 0.7227, 2.41, 0.112, 137, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
958, p4i7iA1, 0.7227, 2.41, 0.112, 140, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT L14R
959, d2axmA_, 0.7227, 2.66, 0.136, 150, 118, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
960, d1g9cA2, 0.7227, 2.42, 0.103, 140, 116, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
961, p4i4sB_, 0.7226, 2.30, 0.096, 128, 115, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
962, d3k1xD_, 0.7226, 2.37, 0.095, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
963, d4qo3B1, 0.7225, 2.42, 0.112, 138, 116, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
964, d4qo3A1, 0.7225, 2.44, 0.112, 137, 116, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
965, d3fjiD1, 0.7225, 2.76, 0.059, 171, 119, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
966, d3o3qB_, 0.7224, 2.44, 0.112, 137, 116, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
967, d5jmcC2, 0.7223, 2.42, 0.112, 140, 116, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
968, d3o3qA_, 0.7223, 2.44, 0.112, 142, 116, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
969, d1e0oA_, 0.7221, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
970, d5moyA2, 0.7220, 2.36, 0.095, 129, 116, CRYSTAL STRUCTURE OF THE BONT/A2 RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF ITS NEURONAL RECEPTOR SV2C
971, p5fozB1, 0.7220, 2.38, 0.112, 138, 116, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
972, p2nz9A4, 0.7220, 2.40, 0.103, 137, 116, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
973, p4tlwA3, 0.7219, 2.40, 0.103, 137, 116, CARDS TOXIN FULL-LENGTH
974, p4i4uB_, 0.7218, 2.42, 0.103, 137, 116, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
975, d3oj2B_, 0.7218, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
976, d3n7lA2, 0.7218, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN
977, p6b0tD3, 0.7217, 2.42, 0.103, 137, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
978, p4i4yD_, 0.7217, 2.41, 0.121, 137, 116, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
979, d3ud9B_, 0.7217, 2.40, 0.103, 131, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
980, d3ud8C_, 0.7217, 2.06, 0.062, 123, 112, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
981, d3oj2A_, 0.7217, 2.41, 0.112, 137, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
982, d1djsB_, 0.7217, 2.21, 0.115, 123, 113, LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1
983, d4fvvB2, 0.7216, 2.84, 0.059, 169, 119, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
984, d2nyyA4, 0.7216, 2.44, 0.103, 137, 116, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
985, d1hknF_, 0.7216, 2.42, 0.121, 137, 116, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
986, p4isqC2, 0.7214, 2.76, 0.082, 203, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
987, d3p53B3, 0.7214, 2.43, 0.103, 137, 116, STRUCTURE OF FASCIN
988, p4i4sD_, 0.7213, 2.37, 0.095, 132, 116, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
989, p3wa1A2, 0.7213, 2.41, 0.103, 137, 116, CRYSTAL STRUCTURE OF BINB: A RECEPTOR BINDING COMPONENT OF THE BINARY TOXIN FROM LYSINIBACILLUS SPHAERICUS
990, d1k5vA_, 0.7213, 2.97, 0.081, 205, 123, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
991, p4i8mA2, 0.7212, 2.37, 0.095, 134, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT V219I
992, d3ud8B_, 0.7212, 2.35, 0.104, 128, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
993, d3ilaA_, 0.7212, 2.37, 0.095, 129, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
994, d2uusB_, 0.7212, 2.79, 0.133, 146, 120, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
995, d3llpB3, 0.7211, 2.37, 0.095, 129, 116, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
996, d3cu1D_, 0.7211, 2.38, 0.095, 134, 116, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
997, d1f31A2, 0.7211, 2.74, 0.090, 193, 122, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE
998, d5l21A2, 0.7210, 2.81, 0.084, 182, 119, CRYSTAL STRUCTURE OF BONT/A RECEPTOR BINDING DOMAIN IN COMPLEX WITH VHH C2
999, p4isqA2, 0.7210, 2.37, 0.095, 132, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
1000, d3ilaE_, 0.7210, 2.44, 0.103, 137, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1001, d3azwA2, 0.7210, 2.38, 0.095, 133, 116, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1002, p2nz9B4, 0.7210, 2.81, 0.133, 146, 120, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
1003, d1i1eA2, 0.7210, 2.07, 0.062, 121, 112, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
1004, d1hknB_, 0.7210, 2.95, 0.089, 212, 123, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
1005, p5x1oB_, 0.7209, 2.44, 0.103, 137, 116, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
1006, p4i4uC_, 0.7209, 2.38, 0.095, 134, 116, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
1007, p5foyB1, 0.7208, 2.44, 0.103, 137, 116, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
1008, p4i4oB_, 0.7208, 2.38, 0.095, 134, 116, BEL BETA-TREFOIL APO CRYSTAL FORM 1
1009, d3llpA3, 0.7208, 2.38, 0.095, 134, 116, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1010, p5x1oA_, 0.7207, 2.37, 0.095, 129, 116, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
1011, p4i4rA_, 0.7206, 2.81, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 4
1012, d1axmA_, 0.7206, 2.72, 0.059, 168, 118, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1013, p4i8mA1, 0.7205, 2.42, 0.112, 138, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT V219I
1014, d4govB3, 0.7204, 2.44, 0.103, 137, 116, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1015, p4i4vB_, 0.7203, 2.43, 0.112, 137, 116, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
1016, d3o3qC_, 0.7203, 2.86, 0.133, 146, 120, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1017, p6b0tD1, 0.7202, 2.45, 0.103, 130, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1018, d3n7mA2, 0.7202, 2.09, 0.062, 123, 112, CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995
1019, p4i4rB_, 0.7201, 2.82, 0.084, 178, 119, BEL BETA-TREFOIL APO CRYSTAL FORM 4
1020, p4isrB2, 0.7200, 2.49, 0.103, 130, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
1021, p4i4yA_, 0.7200, 3.01, 0.065, 211, 124, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
1022, d3azwB2, 0.7200, 2.83, 0.133, 146, 120, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1023, d1barB_, 0.7200, 2.46, 0.103, 130, 116, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
1024, p4isrC2, 0.7197, 2.46, 0.112, 137, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
1025, p4isqB2, 0.7197, 2.45, 0.112, 138, 116, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
1026, d1g9dA2, 0.7197, 2.44, 0.112, 137, 116, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
1027, p4isrA2, 0.7196, 2.17, 0.125, 122, 112, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
1028, p4i4sA_, 0.7196, 2.76, 0.082, 191, 122, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
1029, d1s0gA2, 0.7196, 2.17, 0.125, 123, 112, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
1030, d1axmF_, 0.7196, 2.39, 0.104, 129, 115, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1031, p6b0tF3, 0.7195, 2.88, 0.081, 194, 123, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1032, p4i4vD_, 0.7195, 2.48, 0.122, 170, 115, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
1033, d1s0eA2, 0.7195, 2.99, 0.081, 204, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
1034, p6b0tC1, 0.7194, 3.09, 0.104, 172, 125, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1035, d3o3qD_, 0.7194, 3.09, 0.104, 172, 125, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1036, d1s0dA2, 0.7194, 2.82, 0.133, 146, 120, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
1037, p4i4vC_, 0.7193, 2.45, 0.103, 135, 116, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
1038, p4i4rC_, 0.7193, 2.69, 0.066, 208, 121, BEL BETA-TREFOIL APO CRYSTAL FORM 4
1039, d4eeeB_, 0.7193, 2.09, 0.062, 123, 112, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
1040, d1s0cA2, 0.7193, 2.82, 0.133, 146, 120, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
1041, d3btaA2, 0.7192, 2.35, 0.113, 128, 115, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
1042, d1z2vB1, 0.7192, 2.34, 0.113, 129, 115, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1043, p6f0oA2, 0.7191, 2.45, 0.103, 135, 116, BOTULINUM NEUROTOXIN A3 HC DOMAIN
1044, p6b0tE1, 0.7191, 2.44, 0.103, 134, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1045, p6b0tB1, 0.7191, 2.75, 0.066, 207, 122, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1046, p6b0tE3, 0.7190, 2.99, 0.089, 202, 123, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1047, d3rmyB2, 0.7190, 2.35, 0.113, 128, 115, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
1048, d1g9aA2, 0.7190, 2.75, 0.074, 196, 122, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
1049, d2rq9A1, 0.7189, 2.11, 0.062, 123, 112, SOLUTION STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (AFGF) IN THE PRESENCE OF A PROTEIN STABILIZER NDSB-NEW
1050, d1axmE_, 0.7189, 2.85, 0.133, 146, 120, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1051, p4i4xA_, 0.7188, 2.42, 0.123, 159, 114, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
1052, p4i4qA_, 0.7188, 2.37, 0.104, 128, 115, BEL BETA-TREFOIL APO CRYSTAL FORM 3
1053, p4i4yB_, 0.7187, 2.71, 0.060, 171, 117, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
1054, d3oggA2, 0.7187, 2.37, 0.113, 128, 115, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D
1055, d1basA_, 0.7187, 2.33, 0.079, 164, 114, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
1056, p4i4uD_, 0.7186, 2.45, 0.103, 129, 116, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
1057, p4i4sC_, 0.7186, 2.11, 0.062, 119, 112, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
1058, d3cu1B_, 0.7186, 2.49, 0.103, 131, 116, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
1059, d1g9bA2, 0.7186, 2.81, 0.073, 211, 123, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
1060, d1epwA2, 0.7186, 3.02, 0.081, 201, 123, CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
1061, p4i4xB_, 0.7185, 2.76, 0.074, 196, 122, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
1062, d3ilaC_, 0.7185, 2.17, 0.071, 156, 112, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1063, d3obrA2, 0.7184, 2.72, 0.066, 208, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
1064, d3n7jA2, 0.7181, 2.72, 0.066, 208, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
1065, d3llpB1, 0.7180, 2.98, 0.089, 204, 123, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1066, p6f0pA2, 0.7179, 2.85, 0.065, 211, 123, BOTULINUM NEUROTOXIN A4 HC DOMAIN
1067, d1s0bA2, 0.7179, 2.38, 0.104, 128, 115, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
1068, p5mk7A2, 0.7178, 2.41, 0.095, 127, 116, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 2)
1069, d1z2vA1, 0.7178, 2.86, 0.133, 146, 120, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1070, d4iqpA2, 0.7177, 2.49, 0.122, 172, 115, CRYSTAL STRUCTURE OF HCRA-W1266A
1071, p4i4yC_, 0.7177, 2.49, 0.122, 172, 115, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
1072, p4i4xC_, 0.7177, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
1073, p4i4oA_, 0.7177, 2.03, 0.063, 122, 111, BEL BETA-TREFOIL APO CRYSTAL FORM 1
1074, d3ud7C_, 0.7177, 2.41, 0.095, 127, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
1075, d2aqzA1, 0.7177, 2.84, 0.133, 146, 120, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
1076, d2afgC_, 0.7177, 2.48, 0.103, 129, 116, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1077, d1afcF_, 0.7177, 2.72, 0.076, 176, 118, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1078, p6b0tF1, 0.7175, 2.11, 0.062, 123, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1079, d4oefA_, 0.7175, 2.85, 0.133, 146, 120, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S6I2) COMPLEX
1080, d4gp0A1, 0.7175, 2.30, 0.115, 127, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1081, d1afcG_, 0.7175, 2.31, 0.150, 131, 113, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1082, d4gp3A1, 0.7174, 2.92, 0.073, 208, 123, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1083, d1k5uB_, 0.7173, 2.83, 0.133, 146, 120, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
1084, d1afcA_, 0.7172, 2.71, 0.066, 196, 121, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1085, d3ud9A_, 0.7171, 2.86, 0.133, 146, 120, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
1086, d3rmxA2, 0.7171, 2.77, 0.066, 208, 122, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
1087, d2aqzB1, 0.7171, 2.41, 0.103, 138, 116, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
1088, d4gp0B1, 0.7170, 2.77, 0.074, 196, 122, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1089, d1s0fA2, 0.7170, 2.71, 0.066, 196, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
1090, d4govA1, 0.7169, 3.04, 0.065, 211, 124, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1091, d1afcD_, 0.7169, 2.77, 0.074, 196, 122, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1092, d1afcC_, 0.7169, 2.87, 0.133, 146, 120, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1093, p5vmrA2, 0.7168, 2.83, 0.073, 211, 123, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
1094, d1z0hA2, 0.7167, 2.37, 0.113, 128, 115, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
1095, d3p53B1, 0.7166, 2.11, 0.062, 123, 112, STRUCTURE OF FASCIN
1096, d3p53A3, 0.7166, 2.86, 0.133, 146, 120, STRUCTURE OF FASCIN
1097, d1dzcA_, 0.7166, 3.03, 0.065, 211, 124, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR. MUTANT FGF-4-ALA-(23-154) 24 NMR STRUCTURES
1098, d1dllA2, 0.7166, 2.28, 0.150, 131, 113, THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE
1099, d3ud7A_, 0.7165, 2.30, 0.124, 127, 113, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
1100, d3hmyA2, 0.7165, 3.03, 0.065, 211, 124, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2
1101, p5x9zB1, 0.7164, 2.86, 0.133, 146, 120, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
1102, d3hn1A2, 0.7164, 2.73, 0.134, 146, 119, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 AND LACTOSE
1103, p4tlvD3, 0.7163, 2.58, 0.121, 147, 116, CARDS TOXIN NICKED
1104, p4i4uA_, 0.7163, 2.88, 0.065, 211, 123, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
1105, d3obtA2, 0.7163, 3.01, 0.081, 204, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID
1106, d4jraA2, 0.7162, 2.39, 0.113, 136, 115, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
1107, d2q9xA_, 0.7162, 3.00, 0.089, 190, 123, CRYSTAL STRUCTURE OF HIGHLY STABLE MUTANT Q40P/S47I/H93G OF HUMAN FIBROBLAST GROWTH FACTOR-1
1108, d3o8kA3, 0.7161, 2.30, 0.150, 131, 113,  
1109, d2uusA_, 0.7161, 2.32, 0.150, 131, 113, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
1110, d1barA_, 0.7161, 2.11, 0.062, 123, 112, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
1111, d4goyA1, 0.7159, 2.99, 0.092, 198, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1112, d2afgD_, 0.7159, 2.88, 0.065, 211, 123, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1113, d1afcB_, 0.7159, 2.40, 0.112, 134, 116, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1114, p6b0tA1, 0.7158, 2.38, 0.113, 128, 115, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1115, p5mk8A2, 0.7158, 2.86, 0.133, 146, 120, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
1116, p4j23B_, 0.7158, 2.85, 0.133, 146, 120, LOW RESOLUTION CRYSTAL STRUCTURE OF THE FGFR2D2D3/FGF1/SR128545 COMPLEX
1117, p4i1eA1, 0.7158, 2.87, 0.133, 146, 120, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT G249R
1118, p6b0tA3, 0.7157, 3.01, 0.074, 199, 121, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1119, d2j3pA_, 0.7157, 2.28, 0.096, 125, 114, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
1120, d1ytoA1, 0.7157, 2.87, 0.133, 146, 120, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1121, d4gp3B1, 0.7156, 2.89, 0.133, 146, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1122, d1ihkA_, 0.7156, 2.40, 0.104, 128, 115, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 (FGF9)
1123, p6b0tC3, 0.7155, 3.05, 0.065, 211, 124, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1124, d1bfcA_, 0.7155, 2.88, 0.065, 211, 123, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN HEXAMER FRAGMENT
1125, d1bfbA_, 0.7155, 2.87, 0.133, 146, 120, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN TETRAMER FRAGMENT
1126, d1axmC_, 0.7155, 2.29, 0.080, 162, 113, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1127, d5w59A_, 0.7154, 3.01, 0.074, 207, 121, CRYSTAL STRUCTURE OF A MONOMERIC HUMAN FGF9 IN COMPLEX WITH THE ECTODOMAIN OF HUMAN FGFR1C
1128, d4govB1, 0.7153, 3.06, 0.083, 202, 121, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1129, d1ytoB1, 0.7153, 2.34, 0.150, 131, 113, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1130, d1a8dA2, 0.7153, 3.02, 0.089, 203, 123, TETANUS TOXIN C FRAGMENT
1131, d3ilaF_, 0.7151, 3.04, 0.065, 211, 124, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1132, d1ytoD1, 0.7151, 2.84, 0.082, 191, 122, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1133, d1afcH_, 0.7151, 2.40, 0.113, 136, 115, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1134, d4goyB1, 0.7150, 3.02, 0.089, 201, 123, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1135, d3p53A1, 0.7150, 2.88, 0.133, 146, 120, STRUCTURE OF FASCIN
1136, d5vidB2, 0.7149, 2.89, 0.133, 146, 120, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1137, p4i4vA_, 0.7149, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
1138, p4tlvC3, 0.7148, 2.87, 0.133, 146, 120, CARDS TOXIN NICKED
1139, p4tlvA3, 0.7147, 2.33, 0.105, 127, 114, CARDS TOXIN NICKED
1140, d2np0A2, 0.7147, 2.40, 0.113, 136, 115, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
1141, d1dfqA2, 0.7147, 2.36, 0.096, 127, 114, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID
1142, d3udaB_, 0.7144, 2.31, 0.114, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
1143, d3ilaG_, 0.7144, 2.32, 0.150, 131, 113, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1144, d4cjmA_, 0.7143, 2.30, 0.096, 125, 114, CRYSTAL STRUCTURE OF HUMAN FGF18
1145, p4tlvE3, 0.7141, 2.32, 0.150, 132, 113, CARDS TOXIN NICKED
1146, d3o8kA1, 0.7141, 2.32, 0.105, 127, 114,  
1147, d1yxwA2, 0.7140, 2.28, 0.150, 132, 113, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
1148, d1g82C_, 0.7140, 2.36, 0.096, 128, 114, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
1149, d1g82B_, 0.7140, 2.34, 0.114, 127, 114, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
1150, d2nm1A2, 0.7139, 2.35, 0.096, 128, 114, STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR
1151, d2ermA_, 0.7138, 3.11, 0.066, 204, 121, SOLUTION STRUCTURE OF A BIOLOGICALLY ACTIVE HUMAN FGF-1 MONOMER COMPLEXED TO A HEXASACCHARIDE HEPARIN-ANALOGUE
1152, p5mk8B2, 0.7137, 2.40, 0.113, 136, 115, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
1153, d3rmyC2, 0.7137, 2.36, 0.150, 132, 113, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
1154, d3rmyA2, 0.7137, 3.07, 0.065, 200, 124, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
1155, d1afcE_, 0.7137, 2.29, 0.150, 133, 113, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
1156, p5vmrB2, 0.7136, 2.32, 0.114, 127, 114, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
1157, d5vidE2, 0.7136, 2.31, 0.114, 127, 114, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1158, p3h6qA_, 0.7136, 2.81, 0.066, 203, 122, MACROCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
1159, d1yynA2, 0.7136, 2.82, 0.066, 225, 122, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
1160, d2axmB_, 0.7135, 2.82, 0.066, 225, 122, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1161, d1fv3A2, 0.7135, 2.34, 0.150, 131, 113, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
1162, d3ud9C_, 0.7134, 2.17, 0.062, 123, 112, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
1163, d2vxrA2, 0.7134, 2.31, 0.123, 131, 114, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN
1164, d1g82A_, 0.7134, 2.96, 0.050, 205, 121, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
1165, d5vidD2, 0.7132, 2.37, 0.105, 127, 114, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1166, p4tlvB3, 0.7132, 2.97, 0.050, 205, 121, CARDS TOXIN NICKED
1167, d4oeeA_, 0.7132, 2.64, 0.042, 176, 119, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S3I2) COMPLEX
1168, d1d0hA2, 0.7132, 2.98, 0.050, 205, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE
1169, d1diwA2, 0.7131, 3.02, 0.099, 165, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE
1170, p4d0tF2, 0.7129, 2.90, 0.133, 146, 120, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
1171, d1j0sA_, 0.7129, 3.05, 0.074, 204, 121, SOLUTION STRUCTURE OF THE HUMAN INTERLEUKIN-18
1172, p5xa0A1, 0.7128, 3.02, 0.081, 212, 123, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1173, d3rmxD2, 0.7128, 2.33, 0.105, 127, 114, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
1174, d3lnaA1, 0.7127, 2.10, 0.081, 123, 111,  
1175, d3rmxB2, 0.7126, 2.48, 0.103, 131, 116, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
1176, d1g82D_, 0.7126, 2.35, 0.105, 127, 114, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
1177, d1z0hB2, 0.7125, 2.30, 0.159, 132, 113, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
1178, d1af9A2, 0.7123, 2.35, 0.096, 128, 114, TETANUS NEUROTOXIN C FRAGMENT
1179, d3ud7B_, 0.7122, 2.33, 0.105, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
1180, d3rmyD2, 0.7121, 2.33, 0.150, 131, 113, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
1181, d3f1rB_, 0.7121, 3.01, 0.098, 199, 123, CRYSTAL STRUCTURE OF FGF20 DIMER
1182, d3f1rA_, 0.7121, 2.46, 0.112, 134, 116, CRYSTAL STRUCTURE OF FGF20 DIMER
1183, d1fv2A2, 0.7121, 2.57, 0.069, 176, 116, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
1184, d5vidC2, 0.7120, 2.15, 0.062, 123, 112, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1185, d3llpA1, 0.7120, 2.48, 0.095, 134, 116, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1186, d1fv3B2, 0.7119, 2.41, 0.104, 136, 115, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
1187, d1axmD_, 0.7119, 2.36, 0.150, 131, 113, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1188, d1blaA_, 0.7117, 2.45, 0.104, 157, 115, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
1189, d1ytoC1, 0.7116, 2.17, 0.062, 123, 112, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1190, d5vidA2, 0.7115, 2.27, 0.097, 124, 113, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1191, p4tlvF2, 0.7112, 2.26, 0.097, 124, 113, CARDS TOXIN NICKED
1192, d4oegA_, 0.7106, 2.42, 0.113, 127, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S9I2) COMPLEX
1193, p3zxdC2, 0.7106, 2.43, 0.104, 146, 115, WILD-TYPE LYSENIN
1194, d1fgaA_, 0.7106, 2.33, 0.150, 130, 113, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
1195, p5n0cA4, 0.7105, 2.41, 0.104, 136, 115, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
1196, d4kbbB2, 0.7103, 2.98, 0.050, 205, 121, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
1197, d1axmB_, 0.7103, 2.16, 0.072, 162, 111, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
1198, d4kbbA2, 0.7100, 2.42, 0.104, 136, 115, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
1199, d4fgfA_, 0.7100, 2.32, 0.114, 127, 114, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
1200, d3hbwB_, 0.7100, 2.32, 0.159, 131, 113, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
1201, d4cjmB_, 0.7099, 2.23, 0.143, 133, 112, CRYSTAL STRUCTURE OF HUMAN FGF18
1202, d3f62B1, 0.7099, 2.23, 0.143, 133, 112, CRYSTAL STRUCTURE OF HUMAN IL-18 IN COMPLEX WITH ECTROMELIA VIRUS IL- 18 BINDING PROTEIN
1203, p4i96A1, 0.7098, 2.81, 0.074, 216, 122, CRYSTAL STRUCTURE OF THE N-TERMINAL TWO DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RABBIT RYR1) RESIDUES 217-536
1204, d4goyA3, 0.7098, 2.91, 0.133, 146, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1205, d3rmxC2, 0.7098, 3.04, 0.099, 168, 121, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
1206, d3hbwA_, 0.7098, 3.03, 0.099, 168, 121, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
1207, p3zxdA2, 0.7096, 2.82, 0.074, 211, 122, WILD-TYPE LYSENIN
1208, d1qqlA_, 0.7096, 2.98, 0.050, 205, 121, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA
1209, d4jraB2, 0.7093, 2.39, 0.096, 127, 114, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
1210, d3lnaA3, 0.7093, 2.23, 0.071, 160, 112,  
1211, d1z4sB1, 0.7090, 2.48, 0.103, 129, 116, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1212, p3zxgA2, 0.7089, 3.03, 0.099, 168, 121, LYSENIN SPHINGOMYELIN COMPLEX
1213, p5n0cB4, 0.7087, 2.31, 0.124, 130, 113, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
1214, p3zxdB2, 0.7087, 3.00, 0.050, 205, 121, WILD-TYPE LYSENIN
1215, p3zxdD2, 0.7086, 2.47, 0.104, 155, 115, WILD-TYPE LYSENIN
1216, d1k5vB_, 0.7084, 2.44, 0.104, 157, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
1217, p5ec5S2, 0.7081, 2.83, 0.074, 219, 122, CRYSTAL STRUCTURE OF LYSENIN PORE
1218, p4i37A1, 0.7080, 2.57, 0.121, 133, 116, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT R402G
1219, p5gaqF2, 0.7079, 3.04, 0.089, 198, 123, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1220, d4cjmC_, 0.7078, 3.13, 0.082, 204, 122, CRYSTAL STRUCTURE OF HUMAN FGF18
1221, d3udaA_, 0.7078, 2.89, 0.092, 198, 119, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
1222, p5ec5A2, 0.7077, 2.35, 0.114, 127, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1223, p3zxgB2, 0.7077, 2.87, 0.066, 201, 122, LYSENIN SPHINGOMYELIN COMPLEX
1224, p4i0yA1, 0.7076, 2.75, 0.066, 209, 121, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT C36R
1225, d1z4sC1, 0.7075, 3.01, 0.092, 168, 120, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1226, p5gaqI2, 0.7074, 3.01, 0.092, 168, 120, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1227, p5gaqH2, 0.7074, 3.00, 0.050, 205, 121, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1228, p5gaqG2, 0.7074, 2.41, 0.105, 127, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1229, p5gaqE2, 0.7074, 2.84, 0.050, 205, 120, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1230, p5gaqD2, 0.7074, 2.39, 0.105, 127, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1231, p5gaqC2, 0.7074, 2.98, 0.081, 207, 123, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1232, p5gaqA2, 0.7074, 2.46, 0.096, 157, 115, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1233, p5gaqB2, 0.7073, 2.46, 0.096, 157, 115, CRYO-EM STRUCTURE OF THE LYSENIN PORE
1234, p5ec5L2, 0.7073, 2.89, 0.073, 223, 123, CRYSTAL STRUCTURE OF LYSENIN PORE
1235, p2xoaA1, 0.7073, 3.05, 0.099, 168, 121, CRYSTAL STRUCTURE OF THE N-TERMINAL THREE DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RYR1)
1236, d1q1uA_, 0.7073, 2.40, 0.096, 132, 115, CRYSTAL STRUCTURE OF HUMAN FHF1B (FGF12B)
1237, p5ec5O2, 0.7072, 2.98, 0.050, 205, 121, CRYSTAL STRUCTURE OF LYSENIN PORE
1238, d1z4sA1, 0.7071, 2.99, 0.050, 205, 121, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1239, p5hpzA_, 0.7068, 2.28, 0.117, 121, 111, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
1240, p5ec5I2, 0.7068, 2.95, 0.132, 157, 121, CRYSTAL STRUCTURE OF LYSENIN PORE
1241, p5n0bA4, 0.7067, 2.95, 0.132, 157, 121, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A
1242, p5ec5J2, 0.7067, 2.73, 0.042, 175, 119, CRYSTAL STRUCTURE OF LYSENIN PORE
1243, d3zc9A_, 0.7067, 3.12, 0.074, 204, 122, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 4.6
1244, d3o8kA2, 0.7067, 2.35, 0.150, 130, 113,  
1245, p6b0tB2, 0.7066, 3.13, 0.083, 204, 121, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1246, d4jpzE_, 0.7066, 2.47, 0.096, 155, 115, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
1247, d3zc8A_, 0.7066, 2.91, 0.049, 225, 123, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 7.0
1248, d4cjmD_, 0.7065, 3.00, 0.050, 205, 121, CRYSTAL STRUCTURE OF HUMAN FGF18
1249, p6b0tD2, 0.7064, 2.37, 0.105, 127, 114, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1250, p5ec5H2, 0.7064, 2.97, 0.083, 204, 120, CRYSTAL STRUCTURE OF LYSENIN PORE
1251, p5ec5P2, 0.7063, 2.48, 0.096, 157, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
1252, d4gp3A3, 0.7063, 2.48, 0.096, 157, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1253, p5ec5E2, 0.7062, 3.00, 0.050, 205, 121, CRYSTAL STRUCTURE OF LYSENIN PORE
1254, d1z4sD1, 0.7060, 2.93, 0.065, 223, 123, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
1255, p5x9zA1, 0.7059, 2.46, 0.134, 129, 112, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
1256, p5ec5C2, 0.7059, 3.01, 0.050, 205, 121, CRYSTAL STRUCTURE OF LYSENIN PORE
1257, p2dreD_, 0.7059, 2.39, 0.105, 126, 114, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1258, d1dfcB1, 0.7059, 2.41, 0.095, 155, 116, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1259, p5ec5M2, 0.7058, 2.41, 0.095, 155, 116, CRYSTAL STRUCTURE OF LYSENIN PORE
1260, p5ec5D2, 0.7058, 2.45, 0.113, 136, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
1261, p5ec5K2, 0.7057, 2.94, 0.065, 218, 123, CRYSTAL STRUCTURE OF LYSENIN PORE
1262, p5ec5G2, 0.7057, 3.01, 0.100, 164, 120, CRYSTAL STRUCTURE OF LYSENIN PORE
1263, p4ihzA_, 0.7056, 2.30, 0.097, 124, 113, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
1264, p5ec5B2, 0.7055, 2.61, 0.140, 139, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1265, d1dfcA1, 0.7054, 2.33, 0.097, 124, 113, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1266, p5hpzB_, 0.7050, 2.89, 0.050, 205, 120, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
1267, d1dfcA3, 0.7049, 2.87, 0.066, 199, 122, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1268, p6b0tA2, 0.7048, 2.41, 0.096, 126, 114, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1269, p5ec5R2, 0.7048, 2.88, 0.066, 199, 122, CRYSTAL STRUCTURE OF LYSENIN PORE
1270, p5ec5N2, 0.7048, 2.31, 0.097, 124, 113, CRYSTAL STRUCTURE OF LYSENIN PORE
1271, d4dckC_, 0.7045, 2.58, 0.148, 149, 115, CRYSTAL STRUCTURE OF THE C-TERMINUS OF VOLTAGE-GATED SODIUM CHANNEL IN COMPLEX WITH FGF13 AND CAM
1272, d3p53B2, 0.7045, 2.46, 0.104, 128, 115, STRUCTURE OF FASCIN
1273, d3ilaH_, 0.7045, 2.48, 0.159, 144, 113, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1274, p2dreC_, 0.7045, 2.62, 0.061, 149, 114, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1275, d4jpzA_, 0.7043, 2.11, 0.073, 117, 110, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
1276, p5ec5F2, 0.7042, 3.04, 0.083, 204, 120, CRYSTAL STRUCTURE OF LYSENIN PORE
1277, p3s8kA_, 0.7042, 2.58, 0.148, 149, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
1278, d3iirA_, 0.7042, 2.58, 0.148, 149, 115, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
1279, d3p53A2, 0.7041, 2.64, 0.140, 139, 114, STRUCTURE OF FASCIN
1280, d1qqkA_, 0.7038, 2.47, 0.096, 131, 115, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR)
1281, d3iirB_, 0.7036, 2.97, 0.090, 208, 122, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
1282, d1dfcB2, 0.7035, 2.20, 0.071, 123, 112, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1283, p6b0tE2, 0.7034, 2.20, 0.071, 123, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1284, p6b0tC2, 0.7032, 2.41, 0.114, 135, 114, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1285, p4i6iA1, 0.7032, 2.80, 0.139, 139, 115, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-559) DISEASE MUTANT R45C
1286, d4gp3B3, 0.7031, 2.91, 0.050, 207, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1287, d1nunA_, 0.7031, 2.50, 0.142, 141, 113, CRYSTAL STRUCTURE ANALYSIS OF THE FGF10-FGFR2B COMPLEX
1288, d3pmeA2, 0.7030, 2.50, 0.142, 141, 113, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE
1289, d4gp0A3, 0.7029, 2.50, 0.142, 138, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1290, d3hsmB_, 0.7027, 2.36, 0.115, 126, 113, CRYSTAL STRUCTURE OF DISTAL N-TERMINAL BETA-TREFOIL DOMAIN OF RYANODINE RECEPTOR TYPE 1
1291, d1dfcA2, 0.7027, 2.70, 0.140, 140, 114, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1292, p5uc6A_, 0.7022, 2.72, 0.078, 178, 115, STRUCTURAL INSIGHTS INTO IL-1 ALPHA RECOGNITION BY A NAPHTHYL-MODIFIED APTAMER THAT MIMICS IL-1RI DOMAIN III
1293, p6b0tF2, 0.7021, 2.68, 0.140, 140, 114, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1294, d4goyA2, 0.7021, 2.48, 0.104, 128, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1295, d4f83A2, 0.7021, 2.37, 0.106, 126, 113, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE
1296, d4gp3A2, 0.7017, 2.82, 0.139, 140, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1297, d1bldA_, 0.7015, 2.64, 0.140, 140, 114, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
1298, d3hsmA_, 0.7014, 2.68, 0.069, 173, 116, CRYSTAL STRUCTURE OF DISTAL N-TERMINAL BETA-TREFOIL DOMAIN OF RYANODINE RECEPTOR TYPE 1
1299, p5yczB_, 0.7013, 2.44, 0.114, 135, 114, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
1300, p5x9zA3, 0.7012, 2.68, 0.140, 140, 114, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
1301, d3lnaB3, 0.7008, 2.68, 0.140, 140, 114,  
1302, d3o8kB3, 0.7007, 2.68, 0.140, 140, 114,  
1303, d4gp3B2, 0.7004, 2.68, 0.140, 140, 114, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1304, d5v38A2, 0.7002, 2.68, 0.140, 140, 114, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
1305, p4ihzB_, 0.7002, 2.68, 0.140, 140, 114, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
1306, d1ijtA_, 0.7002, 2.68, 0.140, 140, 114, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 4 (FGF4)
1307, d2kh2A_, 0.6996, 2.68, 0.140, 140, 114, SOLUTION STRUCTURE OF A SCFV-IL-1B COMPLEX
1308, p5yczA_, 0.6995, 2.69, 0.140, 140, 114, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
1309, d5fzyB_, 0.6994, 2.76, 0.078, 174, 115, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP C2221 AND PH 3.5
1310, d4ekxB_, 0.6993, 2.58, 0.130, 138, 115, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
1311, p4ii0A_, 0.6992, 2.82, 0.139, 140, 115, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
1312, d5fzyA_, 0.6986, 2.43, 0.114, 135, 114, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP C2221 AND PH 3.5
1313, p3s8kB_, 0.6986, 2.90, 0.085, 175, 117, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
1314, p2dreB_, 0.6985, 2.90, 0.085, 175, 117, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1315, d4govB2, 0.6983, 2.70, 0.140, 140, 114, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1316, d4goyB2, 0.6982, 2.93, 0.050, 207, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1317, p3zx7A2, 0.6982, 2.93, 0.050, 207, 120, COMPLEX OF LYSENIN WITH PHOSPHOCHOLINE
1318, d3i2aA1, 0.6982, 2.82, 0.139, 140, 115, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
1319, d3lnaA2, 0.6981, 2.81, 0.127, 182, 118,  
1320, d1dfcB3, 0.6980, 2.06, 0.119, 119, 109, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1321, p2yugA_, 0.6979, 2.47, 0.125, 122, 112, SOLUTION STRUCTURE OF MOUSE FRG1 PROTEIN
1322, d3tc2B_, 0.6978, 2.60, 0.139, 148, 115, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
1323, d4gp0B2, 0.6976, 2.83, 0.127, 182, 118, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1324, p3s8jB_, 0.6975, 2.49, 0.104, 129, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
1325, d5tpbA2, 0.6974, 2.50, 0.124, 122, 113, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
1326, p3javD1, 0.6969, 2.68, 0.140, 140, 114, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1327, p3javC1, 0.6969, 2.81, 0.139, 140, 115, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1328, p3javB1, 0.6969, 2.04, 0.064, 120, 109, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1329, p3javA1, 0.6969, 2.83, 0.139, 140, 115, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1330, d5dzuB_, 0.6968, 2.44, 0.123, 135, 114, STRUCTURE OF POTATO CATHEPSIN D INHIBITOR
1331, p4jq0A_, 0.6966, 2.74, 0.051, 176, 118, VOLTAGE-GATED SODIUM CHANNEL 1.5 C-TERMINAL DOMAIN IN COMPLEX WITH FGF12B AND CA2+/CALMODULIN
1332, d5v38B2, 0.6963, 2.69, 0.140, 140, 114, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
1333, d3azvA2, 0.6963, 2.90, 0.084, 177, 119, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1334, d5fnwA_, 0.6959, 2.51, 0.133, 125, 113, CRYSTAL STRUCTURE AT PH 7.0 OF A POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 9.0
1335, d5fnxA_, 0.6958, 2.68, 0.140, 140, 114, CRYSTAL STRUCTURE AT PH 9.0 OF A POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 9.0
1336, p4ii0B_, 0.6952, 2.72, 0.140, 140, 114, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
1337, d3qr5B_, 0.6951, 2.70, 0.140, 140, 114, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
1338, d5fzuA_, 0.6949, 2.71, 0.140, 140, 114, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 7.2
1339, d3mppG2, 0.6949, 2.90, 0.084, 163, 119, BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN
1340, d3azvB2, 0.6949, 2.90, 0.084, 163, 119, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1341, d5g00A_, 0.6948, 2.70, 0.140, 140, 114, CRYSTAL STRUCTURE OF A POTATO STI-KUNITZ BIFUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 7.4
1342, d3llpB2, 0.6947, 2.51, 0.133, 125, 113, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1343, d4govA3, 0.6943, 2.90, 0.085, 175, 117, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1344, d3tc2A_, 0.6943, 2.15, 0.073, 120, 110, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
1345, d3tc2C_, 0.6939, 2.53, 0.133, 122, 113, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
1346, d5fzzA_, 0.6938, 2.70, 0.140, 140, 114, CRYSTAL STRUCTURE OF POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P22121 AND PH 7.0
1347, p4an6B_, 0.6933, 2.56, 0.142, 140, 113, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
1348, d1qqkB_, 0.6933, 2.64, 0.139, 148, 115, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR)
1349, p3h6rB_, 0.6928, 2.26, 0.118, 119, 110, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
1350, d2l5xD_, 0.6928, 2.16, 0.073, 159, 110, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1351, p3v0bB3, 0.6924, 2.90, 0.084, 177, 119, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
1352, p3v0aB3, 0.6924, 2.90, 0.084, 177, 119, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
1353, d4eeeD_, 0.6921, 2.62, 0.139, 148, 115, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
1354, d3i29B_, 0.6921, 2.72, 0.140, 140, 114, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN MUTANT TRYPSIN INHIBITOR WITH BOVINE TRYPSIN
1355, d2bebB_, 0.6920, 2.71, 0.061, 183, 115, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
1356, p5x9zB3, 0.6919, 2.71, 0.061, 183, 115, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
1357, d3llpA2, 0.6917, 2.90, 0.119, 190, 118, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1358, d4gp0A2, 0.6916, 2.90, 0.119, 190, 118, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1359, d3ilaB_, 0.6914, 2.26, 0.127, 119, 110, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
1360, d5dzuA_, 0.6912, 2.51, 0.070, 129, 114, STRUCTURE OF POTATO CATHEPSIN D INHIBITOR
1361, p3s8jA_, 0.6912, 2.90, 0.119, 190, 118, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
1362, d2l5xA_, 0.6908, 2.27, 0.118, 119, 110, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1363, d5bowA1, 0.6906, 2.37, 0.125, 122, 112, CRYSTAL STRUCTURE OF IL-38
1364, d3rsjB2, 0.6904, 2.31, 0.126, 122, 111, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1365, d2ilaA_, 0.6900, 2.87, 0.078, 171, 115, STRUCTURE OF INTERLEUKIN 1ALPHA AT 2.7-ANGSTROMS RESOLUTION
1366, p5wvxA_, 0.6899, 2.08, 0.055, 120, 109, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
1367, d3rsjD2, 0.6891, 2.60, 0.078, 139, 115, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1368, d3rsjA2, 0.6885, 2.60, 0.078, 139, 115, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1369, p5vi4D_, 0.6884, 3.23, 0.082, 193, 122, IL-33/ST2/IL-1RACP TERNARY COMPLEX STRUCTURE
1370, d3rsjC2, 0.6879, 2.02, 0.065, 119, 108, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1371, d2iwtB_, 0.6878, 2.32, 0.081, 159, 111, THIOREDOXIN H2 (HVTRXH2) IN A MIXED DISULFIDE COMPLEX WITH THE TARGET PROTEIN BASI
1372, d41biA_, 0.6874, 2.28, 0.118, 119, 110, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)
1373, d3veqA_, 0.6874, 2.28, 0.118, 119, 110, A BINARY COMPLEX BETWWEN BOVINE PANCREATIC TRYPSIN AND A ENGINEERED MUTANT TRYPSIN INHIBITOR
1374, d3bx1D_, 0.6870, 2.65, 0.061, 151, 115, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
1375, d6i1bA_, 0.6868, 2.57, 0.124, 122, 113, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1376, d3ltqA_, 0.6867, 2.06, 0.130, 117, 108, STRUCTURE OF INTERLEUKIN 1B SOLVED BY SAD USING AN INSERTED LANTHANIDE BINDING TAG
1377, d2gzbA1, 0.6867, 3.23, 0.082, 209, 122, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
1378, d31biA_, 0.6866, 3.23, 0.082, 209, 122, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)
1379, d1iobA_, 0.6864, 2.03, 0.130, 117, 108, INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT
1380, d4ha2A_, 0.6862, 2.51, 0.086, 155, 116, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
1381, d1s0lA_, 0.6862, 2.26, 0.072, 164, 111, INTERLEUKIN 1 BETA MUTANT F42W
1382, p5vi4A_, 0.6860, 2.71, 0.078, 172, 116, IL-33/ST2/IL-1RACP TERNARY COMPLEX STRUCTURE
1383, d1hceA_, 0.6860, 2.83, 0.100, 172, 120, STRUCTURE OF HISACTOPHILIN IS SIMILAR TO INTERLEUKIN-1 BETA AND FIBROBLAST GROWTH FACTOR
1384, d21biA_, 0.6859, 2.14, 0.092, 120, 109, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)
1385, d1tp0A_, 0.6856, 2.15, 0.092, 120, 109, TRIPLE MUTATION IN INTERLEUKIN 1 BETA CAVITY:REPLACEMENT OF PHENYLALANINES WITH TRYPTOPHAN.
1386, d2et2A_, 0.6854, 2.40, 0.136, 119, 110, CRYSTAL STRUCTURE OF AN ASN TO ALA MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1387, p3h6rA_, 0.6853, 2.95, 0.099, 209, 121, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
1388, d2i1bA_, 0.6853, 2.95, 0.076, 163, 119, CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION
1389, d1tweA_, 0.6853, 2.47, 0.114, 128, 114, INTERLEUKIN 1 BETA MUTANT F101Y
1390, d1i1bA_, 0.6853, 2.47, 0.114, 128, 114, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
1391, d5i1bA_, 0.6852, 2.80, 0.069, 153, 116, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
1392, d4ha2B_, 0.6852, 2.91, 0.076, 178, 118, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
1393, d1t4qA_, 0.6852, 2.87, 0.103, 185, 117, INTERLEUKIN 1 BETA F101W
1394, d4govA2, 0.6851, 2.73, 0.132, 142, 114, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1395, d4i1bA_, 0.6850, 2.96, 0.084, 163, 119, FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE
1396, d4tlpA_, 0.6848, 2.95, 0.077, 185, 117, CRYSTAL STRUCTURE OF A ALANINE91 MUTANT OF WCI
1397, d1twmA_, 0.6848, 2.76, 0.061, 182, 115, INTERLEUKIN-1 BETA MUTANT F146Y
1398, d1tooA_, 0.6848, 2.80, 0.085, 173, 117, INTERLEUKIN 1B MUTANT F146W
1399, d2wbcA_, 0.6846, 2.47, 0.136, 119, 110, REFINED CRYSTAL STRUCTURE (2.3 ANGSTROM) OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR AND LOCATION OF ITS SECOND REACTIVE SITE
1400, d1wbcA_, 0.6846, 2.49, 0.127, 119, 110, CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF PSOPHOCARPIN B1 A CHYMOTRYPSIN INHIBITOR FROM WINGED BEAN SEEDS
1401, d2gzbB1, 0.6845, 2.64, 0.143, 140, 112, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
1402, p3h6sG_, 0.6842, 2.81, 0.043, 176, 117, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1403, d7i1bA_, 0.6840, 2.30, 0.127, 119, 110, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1404, d2p39A_, 0.6840, 2.16, 0.073, 119, 109, CRYSTAL STRUCTURE OF HUMAN FGF23
1405, d3bx1C_, 0.6838, 2.60, 0.105, 155, 114, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
1406, d1xg6A1, 0.6838, 2.60, 0.105, 155, 114, THE CRYSTAL STRUCTURE OF THE P1 MUTANT (LEU TO ARG)OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR(KUNITZ)SOLVED AT 2.15A RESOLUTION
1407, d3qr5A_, 0.6837, 2.79, 0.095, 177, 116, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
1408, d2bebA_, 0.6835, 2.46, 0.136, 119, 110, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
1409, d9ilbA_, 0.6833, 2.76, 0.061, 181, 115, HUMAN INTERLEUKIN-1 BETA
1410, p3ffzA3, 0.6832, 2.77, 0.085, 204, 117, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
1411, p3vuoA4, 0.6829, 2.95, 0.025, 176, 121, CRYSTAL STRUCTURE OF NONTOXIC NONHEMAGGLUTININ SUBCOMPONENT (NTNHA) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
1412, d2beaB_, 0.6827, 2.95, 0.025, 176, 121, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
1413, d4depA_, 0.6824, 2.95, 0.025, 176, 121, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
1414, d1eylA_, 0.6823, 2.95, 0.025, 176, 121, STRUCTURE OF A RECOMBINANT WINGED BEAN CHYMOTRYPSIN INHIBITOR
1415, d1fmzA1, 0.6820, 2.88, 0.103, 176, 117, CRYSTAL STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14K.
1416, d4depD1, 0.6818, 2.67, 0.113, 141, 115, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
1417, d3i2aB1, 0.6817, 2.85, 0.101, 206, 119, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
1418, d2nvhA_, 0.6817, 2.71, 0.068, 203, 117, DETERMINATION OF SOLVENT CONTENT IN CAVITIES IN INTERLEUKIN- 1 USING EXPERIMENTALLY-PHASED ELECTRON DENSITY
1419, d2esuA_, 0.6813, 2.93, 0.103, 185, 117, CRYSTAL STRUCTURE OF ASN TO GLN MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1420, d1fmmS_, 0.6813, 2.91, 0.103, 185, 117, SOLUTION STRUCTURE OF NFGF-1
1421, p3ffzB3, 0.6812, 3.00, 0.084, 163, 119, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
1422, d1r8nA_, 0.6811, 2.06, 0.093, 154, 107, THE CRYSTAL STRUCTURE OF THE KUNITZ (STI) TYPE INHIBITOR FROM SEEDS OF DELONIX REGIA
1423, p4g6jA_, 0.6808, 2.91, 0.085, 185, 117, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
1424, d2qyiD_, 0.6807, 3.02, 0.083, 192, 121, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
1425, d4wbcA_, 0.6805, 2.79, 0.059, 203, 118, 2.13 A STRUCTURE OF A KUNITZ-TYPE WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1426, p5w21B_, 0.6802, 2.90, 0.085, 185, 117, CRYSTAL STRUCTURE OF A 1:1:1 FGF23-FGFR1C-AKLOTHO TERNARY COMPLEX
1427, d2mibA_, 0.6799, 2.18, 0.139, 117, 108, THE STRUCTURE OF MURINE INTERLEUKIN-1 BETA AT 2.8 ANGSTROMS RESOLUTION
1428, d3fuqA2, 0.6797, 2.20, 0.056, 115, 108, GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F
1429, d2beaA_, 0.6796, 2.96, 0.103, 181, 117, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
1430, d1fn0A_, 0.6793, 2.94, 0.094, 178, 117, STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14D.
1431, p3o4oA_, 0.6791, 2.89, 0.085, 185, 117, CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
1432, p3e8lC_, 0.6790, 2.97, 0.078, 171, 116, THE CRYSTAL STRUCTURE OF THE DOUBLE-HEADED ARROWHEAD PROTEASE INHIBITOR A IN COMPLEX WITH TWO TRYPSINS
1433, d3i2xB1, 0.6787, 2.44, 0.071, 125, 112, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
1434, d2qyiB_, 0.6787, 2.77, 0.116, 152, 112, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
1435, p2kllA_, 0.6785, 2.74, 0.078, 151, 116, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-33
1436, p4g6mA_, 0.6784, 2.86, 0.096, 158, 114, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
1437, p3h6sE_, 0.6784, 2.86, 0.096, 158, 114, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1438, p5wvxB_, 0.6783, 2.86, 0.096, 158, 114, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
1439, d1r8o.1, 0.6781, 2.63, 0.143, 141, 112, CRYSTAL STRUCTURE OF AN UNUSUAL KUNITZ-TYPE TRYPSIN INHIBITOR FROM COPAIFERA LANGSDORFFII SEEDS
1440, d5dvhA_, 0.6780, 2.87, 0.051, 175, 117, STRUCTURE OF THE KUNITZ-TYPE CYSTEINE PROTEASE INHIBITOR PCPI-3 FROM POTATO
1441, p3h6sH_, 0.6778, 2.84, 0.051, 173, 117, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1442, p5xa0A3, 0.6776, 2.91, 0.101, 176, 119, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1443, p4zktC2, 0.6776, 1.98, 0.142, 112, 106, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1444, p5xa0B1, 0.6771, 2.17, 0.140, 115, 107, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1445, p4zktE2, 0.6771, 2.26, 0.073, 160, 109, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1446, p4zktA2, 0.6771, 2.90, 0.085, 187, 117, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1447, d3pokA_, 0.6770, 2.90, 0.085, 187, 117, INTERLEUKIN-1-BETA LBT L3 MUTANT
1448, d3nj5A_, 0.6770, 2.83, 0.061, 182, 115, CRYSTAL STRUCTURE OF CHICKEN IL-1 HYDROPHOBIC CAVITY MUTANT 157
1449, d8i1bA_, 0.6768, 2.76, 0.078, 151, 116, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
1450, d1avaD_, 0.6765, 2.79, 0.103, 150, 116, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
1451, d1avaC_, 0.6764, 2.79, 0.103, 150, 116, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
1452, d4x3aA_, 0.6761, 2.63, 0.106, 184, 113, GALLUS INTERLEUKIN-1 BETA MUTANT - R140A
1453, d4h9wA_, 0.6761, 2.69, 0.061, 145, 114, CRYSTAL STRUCTURE OF A METHIONINE MUTANT OF WCI
1454, d3qydC_, 0.6760, 2.72, 0.061, 157, 114, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1455, d4j2kB_, 0.6759, 2.54, 0.107, 184, 112, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
1456, d1itbA_, 0.6757, 2.70, 0.105, 186, 114, TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA
1457, p3h6sF_, 0.6750, 2.37, 0.100, 146, 110, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1458, d1hibA_, 0.6750, 2.64, 0.106, 184, 113, THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN- PROTEIN RECOGNITION
1459, d2go2A1, 0.6749, 3.00, 0.128, 181, 117, CRYSTAL STRUCTURE OF BBKI A KUNITZ-TYPE KALLIKREIN INHIBITOR
1460, d4zotA1, 0.6748, 3.19, 0.059, 150, 119, CRYSTAL STRUCTURE OF BBKI A DISULFIDE-FREE PLASMA KALLIKREIN INHIBITOR AT 1.4 A RESOLUTION
1461, d4j2yA_, 0.6746, 2.88, 0.051, 175, 117, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI IN COMPLEX WITH BOVINE TRYPSIN.
1462, d4gafA_, 0.6743, 3.03, 0.128, 181, 117, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA BOUND TO HUMAN INTERLEUKIN-1 RECEPTOR TYPE 1
1463, d4x39A_, 0.6738, 3.09, 0.076, 153, 118, GALLUS INTERLEUKIN-1 BETA MUTANT - T117A
1464, d4x37A_, 0.6737, 2.94, 0.060, 168, 116, GALLUS INTERLEUKIN-1 MUTANT - E118K
1465, d3qydB_, 0.6736, 2.94, 0.060, 168, 116, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1466, p2dreA_, 0.6736, 2.97, 0.113, 162, 115, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1467, d3i2xA1, 0.6735, 3.19, 0.067, 149, 119, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
1468, d3qydA_, 0.6734, 3.19, 0.067, 153, 119, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1469, p4an6A_, 0.6732, 2.96, 0.051, 174, 117, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
1470, d2wryA_, 0.6728, 3.18, 0.067, 153, 119, CRYSTAL STRUCTURE OF CHICKEN CYTOKINE INTERLEUKIN 1 BETA
1471, d4x38A_, 0.6727, 2.58, 0.089, 146, 112, GALLUS INTERLEUKIN-1 BETA MUTANT - E118A
1472, d1tieA_, 0.6722, 2.47, 0.090, 118, 111, CRYSTAL STRUCTURE OF A KUNITZ-TYPE TRYPSIN INHIBITOR FROM ERYTHRINA CAFFRA SEEDS
1473, d4gaiA_, 0.6720, 3.20, 0.076, 151, 119, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
1474, p3snvA_, 0.6705, 3.24, 0.067, 153, 119, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1475, p3javD3, 0.6700, 2.91, 0.051, 175, 117, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1476, p3javB3, 0.6700, 2.80, 0.108, 152, 111, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1477, d4p0kA_, 0.6699, 2.80, 0.108, 152, 111, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA
1478, p3javC3, 0.6699, 3.20, 0.059, 153, 119, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1479, d2ki6E_, 0.6699, 3.22, 0.059, 153, 119, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1480, d2ki4D_, 0.6699, 3.20, 0.059, 151, 119, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1481, d4p0lA_, 0.6698, 3.18, 0.059, 151, 119, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA WITH ADDITIONAL POINT MUTATIONS
1482, p3javA3, 0.6698, 2.97, 0.051, 173, 117, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1483, d5hn1A_, 0.6697, 3.24, 0.067, 153, 119, CRYSTAL STRUCTURE OF INTERLEUKIN-37
1484, d1ilr1_, 0.6697, 2.04, 0.133, 113, 105, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
1485, p3snvB_, 0.6691, 3.21, 0.067, 151, 119, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1486, p5xozA_, 0.6689, 2.99, 0.051, 175, 117, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
1487, d5mvzV_, 0.6689, 3.22, 0.050, 153, 119, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1488, d4j2kA_, 0.6685, 3.23, 0.050, 153, 119, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
1489, p2qn4A_, 0.6685, 2.91, 0.051, 183, 117, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
1490, p2qn4B_, 0.6684, 2.93, 0.051, 183, 117, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
1491, d2kkiA_, 0.6684, 2.93, 0.051, 183, 117, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN 1A
1492, d5hn1B_, 0.6683, 2.99, 0.113, 162, 115, CRYSTAL STRUCTURE OF INTERLEUKIN-37
1493, d2ki6B_, 0.6682, 2.68, 0.109, 150, 110, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1494, d2ki4A_, 0.6682, 3.20, 0.067, 153, 119, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1495, d2irtB_, 0.6678, 2.57, 0.073, 142, 110, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
1496, d1iraX_, 0.6678, 2.57, 0.073, 142, 110, COMPLEX OF THE INTERLEUKIN-1 RECEPTOR WITH THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA)
1497, d4p0jB_, 0.6677, 3.05, 0.137, 181, 117, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
1498, p4zktB3, 0.6673, 2.98, 0.051, 175, 117, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1499, p4zktF3, 0.6672, 2.00, 0.096, 151, 104, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1500, p4zktD3, 0.6669, 2.96, 0.051, 170, 117, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1501, d1iltB_, 0.6668, 3.15, 0.050, 153, 119, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
1502, d2k4aB_, 0.6662, 2.64, 0.150, 186, 113, FGF-1-C2A BINARY COMPLEX STRUCTURE: A KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
1503, d1iltA_, 0.6661, 2.64, 0.150, 186, 113, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
1504, p5xozB_, 0.6659, 3.13, 0.132, 158, 114, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
1505, d2irtA_, 0.6659, 2.93, 0.051, 170, 117, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
1506, d1ilr2_, 0.6655, 2.99, 0.068, 151, 117, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
1507, p5xa0B5, 0.6639, 2.95, 0.051, 179, 117, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1508, d1l2hA_, 0.6636, 2.95, 0.051, 177, 117, CRYSTAL STRUCTURE OF INTERLEUKIN 1-BETA F42W/W120F MUTANT
1509, d4p0jA_, 0.6633, 3.00, 0.068, 151, 117, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
1510, d1ba7A_, 0.6625, 3.00, 0.043, 176, 117, SOYBEAN TRYPSIN INHIBITOR
1511, d4izeA_, 0.6614, 3.21, 0.050, 152, 119, CRYSTAL STRUCTURE OF IL-36GAMMA
1512, d3lnaB1, 0.6613, 2.94, 0.051, 173, 117,  
1513, d2k8rA_, 0.6611, 2.74, 0.138, 132, 116, SOLUTION STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN COMPLEX WITH ANTI-ANGIOGENIC DRUG INOSITOL HEXAPHOSPHATE (IP6)
1514, d3o8kB1, 0.6610, 2.76, 0.149, 186, 114,  
1515, d5bvpI_, 0.6609, 2.99, 0.078, 185, 116, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
1516, d5dssB_, 0.6598, 2.99, 0.078, 185, 116, MP-4 CONTRIBUTES TO SNAKE VENOM NEUTRALIZATION BY MUCUNA PRURIENS SEEDS THROUGH STIMULATION OF CROSS-REACTIVE ANTIBODIES
1517, d1wbaA_, 0.6592, 2.98, 0.052, 149, 116, WINGED BEAN ALBUMIN 1
1518, d1ba7B_, 0.6589, 3.07, 0.051, 175, 118, SOYBEAN TRYPSIN INHIBITOR
1519, p4kc3A_, 0.6586, 2.97, 0.051, 179, 117, CYTOKINE/RECEPTOR BINARY COMPLEX
1520, p4an7B_, 0.6573, 2.56, 0.073, 142, 110, KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN
1521, p6b0tF4, 0.6563, 3.04, 0.069, 149, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1522, d3lnaB2, 0.6560, 2.54, 0.109, 181, 110,  
1523, d2k43A_, 0.6558, 3.01, 0.051, 170, 117, ACIDIC FIBROBLAST GROWTH FACTOR SOLUTION STRUCTURE IN THE FGF-1-C2A BINARY COMPLEX: KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
1524, d3o8kB2, 0.6549, 2.97, 0.051, 177, 117,  
1525, d2p23A_, 0.6546, 3.26, 0.059, 152, 119, CRYSTAL STRUCTURE OF HUMAN FGF19
1526, d2p23B_, 0.6545, 3.04, 0.103, 176, 116, CRYSTAL STRUCTURE OF HUMAN FGF19
1527, p6b0tC4, 0.6543, 3.04, 0.103, 176, 116, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1528, d3p53A4, 0.6542, 3.01, 0.043, 177, 117, STRUCTURE OF FASCIN
1529, p6b0tE4, 0.6541, 2.97, 0.051, 175, 117, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1530, d4gaiB_, 0.6540, 2.82, 0.154, 161, 117, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
1531, p3p6jA_, 0.6539, 2.82, 0.154, 161, 117, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #3: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1532, p6b0tB4, 0.6538, 3.06, 0.060, 150, 117, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1533, d1avwB_, 0.6537, 2.76, 0.109, 150, 110, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR ORTHORHOMBIC CRYSTAL FORM
1534, p6b0tA4, 0.6531, 2.61, 0.063, 153, 111, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1535, d1avuA_, 0.6531, 2.90, 0.096, 167, 114, TRYPSIN INHIBITOR FROM SOYBEAN (STI)
1536, d3o8kB4, 0.6526, 2.90, 0.096, 167, 114,  
1537, d1avxB_, 0.6523, 3.22, 0.120, 185, 117, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR TETRAGONAL CRYSTAL FORM
1538, d1md6A_, 0.6522, 3.22, 0.120, 185, 117, HIGH RESOLUTION CRYSTAL STRUCTURE OF MURINE IL-1F5 REVEALS UNIQUE LOOP CONFORMATION FOR SPECIFICITY
1539, d1dfcA4, 0.6520, 2.75, 0.100, 150, 110, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1540, d4gp0A4, 0.6518, 3.17, 0.092, 177, 120, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1541, d3lnaB4, 0.6515, 2.68, 0.142, 181, 113,  
1542, d1dfcB4, 0.6515, 2.84, 0.026, 168, 117, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
1543, d4gp3A4, 0.6514, 2.68, 0.142, 181, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1544, d3lnaA4, 0.6507, 2.69, 0.142, 182, 113,  
1545, p6b0tD4, 0.6504, 3.23, 0.050, 159, 120, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
1546, p4tlvA2, 0.6498, 3.23, 0.067, 152, 119, CARDS TOXIN NICKED
1547, d3o8kA4, 0.6496, 3.09, 0.068, 146, 117,  
1548, d3llpB4, 0.6493, 3.18, 0.128, 181, 117, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1549, d1hcdA_, 0.6490, 3.25, 0.144, 181, 118, STRUCTURE OF HISACTOPHILIN IS SIMILAR TO INTERLEUKIN-1 BETA AND FIBROBLAST GROWTH FACTOR
1550, p4tlvE2, 0.6488, 3.25, 0.144, 181, 118, CARDS TOXIN NICKED
1551, p4tlvB2, 0.6488, 2.97, 0.060, 147, 116, CARDS TOXIN NICKED
1552, p4tlwA2, 0.6484, 3.00, 0.051, 177, 117, CARDS TOXIN FULL-LENGTH
1553, p4tlvF3, 0.6481, 3.02, 0.043, 177, 117, CARDS TOXIN NICKED
1554, p4tlvD2, 0.6480, 2.81, 0.097, 167, 113, CARDS TOXIN NICKED
1555, p4tlvC2, 0.6480, 3.06, 0.060, 153, 117, CARDS TOXIN NICKED
1556, d4gp0B4, 0.6479, 2.71, 0.110, 150, 109, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
1557, d3p53B4, 0.6468, 2.99, 0.069, 150, 116, STRUCTURE OF FASCIN
1558, d4gp3B4, 0.6464, 3.03, 0.087, 162, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
1559, d4goyB4, 0.6457, 3.03, 0.087, 162, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1560, d4govB4, 0.6437, 3.02, 0.096, 162, 115, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1561, d3llpA4, 0.6419, 3.13, 0.096, 165, 115, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
1562, d1sr4C_, 0.6418, 3.24, 0.076, 152, 118, CRYSTAL STRUCTURE OF THE HAEMOPHILUS DUCREYI CYTOLETHAL DISTENDING TOXIN
1563, d4goyA4, 0.6405, 3.19, 0.059, 154, 118, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
1564, d4govA4, 0.6400, 3.06, 0.060, 159, 117, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
1565, d1rmlA_, 0.6383, 3.06, 0.060, 159, 117, NMR STUDY OF ACID FIBROBLAST GROWTH FACTOR BOUND TO 136- NAPHTHALENE TRISULPHONATE 26 STRUCTURES
1566, d5mvzU_, 0.6370, 3.03, 0.052, 177, 116, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1567, d1pwaA_, 0.6340, 2.98, 0.113, 172, 115, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 19
1568, d2f2fC1, 0.6289, 3.03, 0.043, 177, 117, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
1569, d2f2fF_, 0.6285, 3.08, 0.043, 177, 117, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
1570, d1dzdA_, 0.6275, 3.01, 0.080, 172, 113, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR (27-154) 24 NMR STRUCTURES
1571, p3p6iA_, 0.6196, 3.01, 0.080, 172, 113, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #2: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1572, d3brdA3, 0.6196, 3.07, 0.060, 154, 117, CSL (LAG-1) BOUND TO DNA WITH LIN-12 RAM PEPTIDE P212121
1573, d1ttuA3, 0.6179, 3.01, 0.060, 149, 116, CRYSTAL STRUCTURE OF CSL BOUND TO DNA
1574, d1irpA_, 0.6165, 3.01, 0.043, 166, 115, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
1575, p4j2xC2, 0.6123, 3.30, 0.068, 152, 118, CSL (RBP-JK) WITH COREPRESSOR KYOT2 BOUND TO DNA
1576, p3iagC3, 0.6123, 2.12, 0.106, 125, 104, CSL (RBP-JK) BOUND TO HES-1 NONCONSENSUS SITE
1577, d3brfA3, 0.6108, 3.00, 0.093, 191, 118, CSL (LAG-1) BOUND TO DNA WITH LIN-12 RAM PEPTIDE C2221
1578, p4j2xA2, 0.6107, 3.00, 0.093, 191, 118, CSL (RBP-JK) WITH COREPRESSOR KYOT2 BOUND TO DNA
1579, p5eg6C3, 0.6101, 2.92, 0.105, 144, 114, CSL-RITA COMPLEX BOUND TO DNA
1580, d2fo1A3, 0.6067, 3.01, 0.093, 191, 118, CRYSTAL STRUCTURE OF THE CSL-NOTCH-MASTERMIND TERNARY COMPLEX BOUND TO DNA
1581, p5e24F3, 0.6059, 2.77, 0.114, 133, 114, STRUCTURE OF THE SU(H)-HAIRLESS-DNA REPRESSOR COMPLEX
1582, p5e24E3, 0.6058, 2.77, 0.114, 133, 114, STRUCTURE OF THE SU(H)-HAIRLESS-DNA REPRESSOR COMPLEX
1583, p3nbnA3, 0.6056, 2.92, 0.105, 143, 114, CRYSTAL STRUCTURE OF A DIMER OF NOTCH TRANSCRIPTION COMPLEX TRIMERS ON HES1 DNA
1584, p3v79C2, 0.6054, 3.01, 0.093, 191, 118, STRUCTURE OF HUMAN NOTCH1 TRANSCRIPTION COMPLEX INCLUDING CSL RAM ANK AND MAML-1 ON HES-1 PROMOTER DNA SEQUENCE
1585, p5e4lB1, 0.6053, 3.01, 0.093, 191, 118, STRUCTURE OF LIGAND BINDING REGION OF UPARAP AT PH 5.3
1586, p3nbnD3, 0.6052, 3.23, 0.102, 157, 118, CRYSTAL STRUCTURE OF A DIMER OF NOTCH TRANSCRIPTION COMPLEX TRIMERS ON HES1 DNA
1587, d3brgC1, 0.6044, 3.23, 0.102, 157, 118, CSL (RBP-JK) BOUND TO DNA
1588, p2f8xC2, 0.6042, 3.28, 0.109, 145, 119, CRYSTAL STRUCTURE OF ACTIVATED NOTCH CSL AND MAML ON HES-1 PROMOTER DNA SEQUENCE
1589, p5e4lA1, 0.6034, 2.13, 0.106, 124, 104, STRUCTURE OF LIGAND BINDING REGION OF UPARAP AT PH 5.3
1590, p5ao5B1, 0.5964, 3.02, 0.062, 178, 113, ENDO180 D1-4 MONOCLINIC FORM
1591, p5ew6A1, 0.5960, 3.07, 0.061, 144, 115, STRUCTURE OF LIGAND BINDING REGION OF UPARAP AT PH 7.4 WITHOUT CALCIUM
1592, p5ao5A1, 0.5951, 3.05, 0.087, 168, 115, ENDO180 D1-4 MONOCLINIC FORM
1593, p5ao6A1, 0.5839, 3.05, 0.087, 168, 115, ENDO180 D1-4 TRIGONAL FORM
1594, p5ao6B1, 0.5833, 2.83, 0.161, 159, 112, ENDO180 D1-4 TRIGONAL FORM
1595, p5e4kA1, 0.5786, 2.82, 0.161, 159, 112, STRUCTURE OF LIGAND BINDING REGION OF UPARAP AT PH 7.4
1596, p5fv9D2, 0.5304, 3.03, 0.078, 151, 116, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
1597, d5jmcG2, 0.5101, 3.03, 0.078, 151, 116, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
